Podcasts about health nih

In this episode of The Heart to Heart podcast, host Dr. Mike Hart welcomes back Rav, an author and host of the Illusion of Consensus podcast. The conversation delves into Rav's evolving interests, from his initial focus on COVID-19 and myocarditis to his current pursuit of a more holistic and spiritually grounded life. Rav discusses his journey through rigorous psychotherapy, aided by psychedelics, to uncover subconscious patterns and improve his overall well-being. The discussion also touches on the utility of AI tools like ChatGPT as supplementary therapy, the impact of social media on Gen Z's social behaviors, and the rising influence of independent journalism. The episode sheds light on finding balance in a hyper-productive world, integrating different therapeutic pathways, and the significance of peaceful presence in one's life. Rav Arora is an independent journalist, cultural critic, and podcast host exploring the intersections of health, spirituality, and human performance. Rising to prominence through his widely read Substack, The Meta Mystic, and as co-host of The Illusion of Consensus podcast, Rav has become a leading voice challenging mainstream narratives in science, psychology, and culture. Follow him here: Substack: The Meta MysticPodcast: The Illusion of ConsensusTwitter/X: @Ravarora1 Links: Psilocybin & Religious Leaders Study Internal Family Systems (IFS) Pain Reprocessing Therapy (PRT) Show Notes: (00:00)Welcome back to the Hart2Heart Podcast with Dr. Mike Hart (01:00) Shifting gears: From COVID to holistic living (02:30) The role of psychedelics in therapy (04:00) Balancing productivity and relaxation (10:00) ChatGPT as a therapeutic tool (18:30) Exploring psychedelic therapy (28:00) The power of peaceful presence (39:00) Psilocybin study on religious leaders (40:30) Challenges in recruiting for the study (41:00) Gen Z and alcohol consumption (42:30) Impact of social media on social skills (43:00) Dating apps and their consequences (50:48) “Social media has provided this illusion and comfort.” (53:30) Independent journalism's rise (01:00:30) The future of media and podcasting   — The Hart2Heart podcast is hosted by family physician Dr. Michael Hart, who is dedicated to  cutting through the noise and uncovering the most effective strategies for optimizing health,  longevity, and peak performance. This podcast dives deep into evidence-based approaches to  hormone balance, peptides, sleep optimization, nutrition, psychedelics, supplements, exercise  protocols, leveraging sunlight light, and de-prescribing pharmaceuticals—using medications only when absolutely necessary.   Beyond health science, we tackle the intersection of public health and politics, exposing how  policy decisions shape our health landscape and what actionable steps people can take to reclaim control over their well-being.   Guests range from out-of-the-box thinking physicians such as Dr. Casey Means (author of "Good Energy") and Dr. Roger Sehult (Medcram lectures) to public health experts such as Dr. Jay Bhattacharya (Director of the National Institutes of Health (NIH) and Dr. Marty Mckary  (Commissioner of the Food and Drug Administration (FDA) and high-profile names such as  Zuby and Mark Sisson (Primal Blueprint and Primal Kitchen).   If you're ready to take control of your health and performance, this is the podcast for you. We cut through the jargon and deliver practical, no-BS advice that you can implement in your daily life, empowering you to make positive changes for your well-being.   Connect on social with Dr. Mike Hart: Instagram: @drmikehart Twitter: @drmikehart Facebook: @drmikehart  

On today’s episode, we interview Dr. Brian Erkkila, the Director of Regulatory Science at Swedish Match North America, a subsidiary of Philip Morris International – makers of ZYN. A former scientist at the Food and Drug Administration’s (FDA) Center for Tobacco Products, Dr. Erkkila offers detailed insights on a new generation of smoke-free products and outlines opportunities for tobacco harm reduction. He also addresses common misconceptions about nicotine and explains how the FDA can do more to arm medical professionals with better advice for their patients who smoke. PMI U.S. recently released a white paper on the topic entitled "Getting Smart on Reduced Harm." Dr. Brian Erkkila is a regulatory scientist with a history of tackling complex regulatory issues, specializing in human health risk assessment, pharmacology, tobacco regulation, database development and science policy. He currently serves as the director of regulatory science at Swedish Match North America, a wholly owned subsidiary of Philip Morris International. Prior to this role, he worked at the Foundation for a Smoke-Free World, the Food and Drug Administration’s (FDA) Center for Tobacco Products, Office of Science, and the National Institutes of Health (NIH). Erkkila holds a BA in Neurobiology from The Johns Hopkins University and earned his PhD in Neurobiology from the University of Alabama at Birmingham. See omnystudio.com/listener for privacy information.

Donna Vogel, MD, PhD, joins us this week to share her journey of recognizing that it was time for retirement and how she optimized her plan using her trademark discipline and scientific vigor to achieve the healthiest possible retirement from a physical, mental, and financial standpoint. This is Dr. Vogel's ninth appearance on the Faculty Factory Podcast, and we are immensely grateful for her selfless and relentless contributions to this community over the years since our 2019 inception. Among her career highlights, she served as Director of the Professional Development Office at Johns Hopkins Medicine and was the Program Director of the Reproductive Medicine grant portfolio at the National Institutes of Health (NIH). She is also a former Jeopardy! champion, having won four consecutive days and reaching the semifinals of the Tournament of Champions. The four pillars of retirement, according to Dr. Vogel, and discussed toward the end of this podcast, are as follows: Financial planning Health and general fitness Things you do for yourself Things you do for others “Above all, keep learning in retirement, as that overlaps with all four pillars and ties them all together. Never stop learning,” Dr. Vogel told us in the closing moments of today's show. Important Resources from Today's Chat Helping Medical Education Faculty Navigate a Post-Academic Landing Pad (Recent Academic Medicine editorial) New York Times article on retirement and mental health referenced by Dr. Vogel The Academy at Johns Hopkins for retired faculty Learning Ally Catch up on Dr. Vogel's Faculty Factory Appearances Networking in a Virtual Environment Applying for Funding, Top Ten Things to Know Be a Memorable Mentor Get That Paper off the Ground How to Turbocharge your Presentation Skills Overcoming Imposter Syndrome Professional Societies, Beyond Getting the Journal Time Management for Faculty Please make sure to listen to today's episode via the podcast player above; and listen to more podcast episodes here.

In this solo podcast episode, Dr Mike Hart provides actionable, evidence-backed strategies to improve overall circadian rhythm and consequently enhance sleep quality. He discusses the importance of a regulated sleep-wake cycle and its impact on hormone release, metabolism, immune function, and general well-being. Various methods to maintain a healthy circadian rhythm are explored, including the benefits of morning sunlight exposure, the role of blue light blocking in the evening, and the timing of meals and exercise. He also touches on the effects of caffeine and alcohol on sleep, the ideal sleep environment, and additional supportive practices like social interaction, light physical activity, and evening routines that promote relaxation.   Links: Dual Orexin Receptor Antagonists (DORAs) Forgiveness & Better Sleep (PubMed) Omega-3 (Fish Oil / EPA)   Show Notes: (0:00) Welcome back to the Hart2Heart Podcast with Dr. Mike Hart (01:30) Natural sleep improvement tips (02:33)  "Cortisol isn't bad—it's about timing. You want it high in the morning and low at night for better sleep." (04:30) Behavioral modifications and supplements (08:30) Introduction to prescription sleep medications (10:00) Dual orexin receptor antagonists (DORAs) (14:30) Z-Drugs: Benefits and risks (18:00) Benzodiazepines: Usage and caution (20:30) Doxepin and H1 inverse agonists (22:30) Gabapentinoids for sleep and pain (26:30) Alpha adrenergic agents (31:30) Sedating antidepressants (37:30) Sodium oxybate for narcolepsy — The Hart2Heart podcast is hosted by family physician Dr. Michael Hart, who is dedicated to  cutting through the noise and uncovering the most effective strategies for optimizing health,  longevity, and peak performance. This podcast dives deep into evidence-based approaches to  hormone balance, peptides, sleep optimization, nutrition, psychedelics, supplements, exercise  protocols, leveraging sunlight light, and de-prescribing pharmaceuticals—using medications only when absolutely necessary.   Beyond health science, we tackle the intersection of public health and politics, exposing how  policy decisions shape our health landscape and what actionable steps people can take to reclaim control over their well-being.   Guests range from out-of-the-box thinking physicians such as Dr. Casey Means (author of "Good Energy") and Dr. Roger Sehult (Medcram lectures) to public health experts such as Dr. Jay Bhattacharya (Director of the National Institutes of Health (NIH) and Dr. Marty Mckary  (Commissioner of the Food and Drug Administration (FDA) and high-profile names such as  Zuby and Mark Sisson (Primal Blueprint and Primal Kitchen).   If you're ready to take control of your health and performance, this is the podcast for you. We cut through the jargon and deliver practical, no-BS advice that you can implement in your daily life, empowering you to make positive changes for your well-being.   Connect on social with Dr. Mike Hart: Instagram: @drmikehart Twitter: @drmikehart Facebook: @drmikehart  

This week on No More Booze, I welcome the renowned Professor David Nutt, psychiatrist and psychoneuropharmacologist and author of the ground breaking book, "Drink: The New Science of Alcohol and Your Health." In this incredible conversation, Professor Nutt dives into the complexities of alcohol, exploring its profound effects on the brain and body. He discusses societal views on alcohol, the emergence of a sober-curious generation and the myths surrounding drinking culture. With insights drawn from decades of research, he offers practical advice for those looking to reassess their relationship with alcohol. Professor Nutt specialises in the study of the brain, drugs, addiction, anxiety, and sleep. David co-founded GABALabs with David Orren to fulfil their shared vision of safer, better choices for adult social drinkers and the current products can be found at sentiaspirits.com. David spent two years as Chief of Clinical Science in the National Institute of Alcohol Abuse and Alcoholism at the National Institute of Health (NIH) in America before setting up the psychopharmacology unit at Bristol University. In 2008 he moved to Imperial College London as the Edmond J. Safra chair in Neuropsychopharmacology. He also currently holds visiting professorships at the Open University and University of Maastricht.David is a prolific speaker and successful author. He won the Transmission Prize for Communicating Science in 2014. David has published over 500 scientific papers, over 30 books, contributed to 8 government reports, and has edited the Journal of Psychopharmacology for 20 years. David earned the distinction of being included by Times Eureka magazine in 2010 as one of the 100 most distinguished figures in British science.David is currently the Founding Chair of DrugScience.org.uk, a charity that researches and tells the truth about all drugs, legal and illegal, free from political or other interference. Enjoy!

His name is Dr. Elias Zerhouni, former director of the National Institutes of Health (NIH) under President George W. Bush, presidential envoy under President Barack Obama and treating physician for President Ronald Reagan. He is the author of "Disease Knows No Politics," an inspirational medical and political memoir that champions the work of the NIH, and he is our guest on the next Another View on Health. Dr. Zerhouni will share why, despite deep cuts in funding by the Trump administration, he believes the NIH needs to be at the service of all Americans, regardless of their political preferences, race, gender, sexual orientation or religion.

In this episode of the Heart to Heart podcast, Dr. Mike Hart hosts Dr. Chester Sokolowski, a peptide expert and the founder of Thrive Telehealth Clinic, which specializes in hormone replacement therapy (HRT) and peptide treatments for both men and women. Dr. Sokolowski discusses his background, career, and various business ventures focused on human performance and optimization. The conversation delves deep into the benefits and applications of testosterone replacement therapy (TRT), peptides, and other health-related topics. Key points include the implications of TRT, managing estrogen levels, the benefits of combining peptides for muscle growth and recovery, and the groundbreaking potential of GLP-1 agonists like Ozempic and Retatrutide for weight loss and metabolic health. Dr. Sokolowski also touches on the benefits of glutathione, the latest research on peptides such as BPC-157 and TB-500, and the ethical considerations of using these therapies in professional sports. Dr. Chester Sokolowski is a performance optimization expert, telehealth clinician, and leading voice in hormone and peptide therapy. He earned his doctoral training at Florida State University and has dedicated his career to human performance, healthspan, and longevity. Known online as “Dr. Soko”, he shares cutting-edge insights on testosterone therapy, peptides, recovery, and performance through social media and educational content. His work empowers people to look, feel, and perform at their absolute best. Follow him on Instagram: @dr.soko, LinkedIn: Dr. Chester Sokolowski and YouTube: Dr. Soko Links: TRT (Testosterone Replacement Therapy) Ozempic (Semaglutide) DIM (Diindolylmethane) Oxidative stress & disease   Show Notes: (00:00) Introduction to the Heart to Heart Podcast (02:30) Dr. soko's dissertation on binge drinking and muscle growth (06:00) Cold therapy and hypertrophy (08:00) TRT and arimidex discussion (13:35) “Estrogen is not the enemy; it's actually protective for your heart, your brain, your joints.” (14:30) HCG and fertility (20:00) Peptides and GLP-1 drugs (34:30) Minimizing side effects and dosage strategies (35:30) Understanding GLP-1 mechanisms (36:00) Red aide: the unique GLP-1 (39:00) Visceral fat and GLP-1 effectiveness (41:00) GLP-1s and impulse control (46:30) Glutathione: the ultimate antioxidant (50:30) Peptides for skin and hair health (51:00) Growth hormone peptides: which is best? (55:00) BPC-157 and tb-500: healing peptides (01:00:30) TRT, peptides, and sports (01:03:00) Conclusion and contact information   — The Hart2Heart podcast is hosted by family physician Dr. Michael Hart, who is dedicated to  cutting through the noise and uncovering the most effective strategies for optimizing health,  longevity, and peak performance. This podcast dives deep into evidence-based approaches to  hormone balance, peptides, sleep optimization, nutrition, psychedelics, supplements, exercise  protocols, leveraging sunlight light, and de-prescribing pharmaceuticals—using medications only when absolutely necessary.   Beyond health science, we tackle the intersection of public health and politics, exposing how  policy decisions shape our health landscape and what actionable steps people can take to reclaim control over their well-being.   Guests range from out-of-the-box thinking physicians such as Dr. Casey Means (author of "Good Energy") and Dr. Roger Sehult (Medcram lectures) to public health experts such as Dr. Jay Bhattacharya (Director of the National Institutes of Health (NIH) and Dr. Marty Mckary  (Commissioner of the Food and Drug Administration (FDA) and high-profile names such as  Zuby and Mark Sisson (Primal Blueprint and Primal Kitchen).   If you're ready to take control of your health and performance, this is the podcast for you. We cut through the jargon and deliver practical, no-BS advice that you can implement in your daily life, empowering you to make positive changes for your well-being.   Connect on social with Dr. Mike Hart: Instagram: @drmikehart Twitter: @drmikehart Facebook: @drmikehart  

The climate crisis is also a health crisis. Rising temperatures and extreme weather events are driving more heat-related deaths, spreading vector-borne diseases, and damaging mental health – impacts that fall hardest on the most vulnerable communities. Framing climate change through the lens of health makes it personal – and the solutions preventative. Clean energy doesn't just cut carbon; it saves lives by cleaning the air we breathe. Greener cities reduce emissions, protect us from heatwaves, and support our wellbeing. In this episode, James and Daisy explore the urgent connections between climate change and health. How is our health already being affected? How can health risks drive climate action? And what solutions offer the greatest benefits for both people and planet?  SOME RECOMMENDATIONS: Outrage + Optimism (2025) – A fantastic podcast episode from Christiana Figueres and Paul Dickinson exploring why health must be central to climate communication. They are joined by Julia Gillard, Chair of the Wellcome Trust.  Force of Nature – Founded by former Fossil vs Future guest, Clover Hogan, this non-profit provides mental health resources and research on the rise of eco-anxiety.OTHER ADVOCATES AND RESOURCES:Our World in Data (2024) – “Almost no one has “heat” or “cold” written on their death certificate, but sub-optimal temperatures lead to a large number of premature deaths.”EAT-Lancet Commission (2019) – Proposes a global planetary health diet that is healthy for both people and planet. NY Times (2025) – The U.S. National Institutes of Health (NIH) will stop funding research on the health effects of climate change.NY Times (2025) – With 59% of its revenue coming from federal and external sponsors, Harvard's School of Public Health faces what has been called an “existential crisis.”Smart Surfaces Coalition – Promotes the adoption of green, porous, and reflective surfaces to enable cities to decrease urban heat, save money, reduce flooding risk, and strengthen urban liveability, resilience, and equity.City of Barcelona – Offers a publicly available map of climate shelters across the city. Wellcome – Showcases climate solutions with health co-benefits, such as protecting forests in Indonesia by meeting community needs. CNN (2023) – Singapore's founding prime minister, Lee Kuan Yew, once called air conditioning “the greatest invention of the 20th century” and credited it for helping to transform the island. Verv – An AI-based smart home product that allows remote control of HVAC units, switching to standby, setting temperature points, and programming set points.NHS & UNHSA (2025) – Partnered with the UK Met Office to integrate climate science and modelling into health impact assessments and launch an impact-based Weather-Health Alerting System.SOME FACTS: WHO (2023): 37% of heat-related deaths can be linked to human-induced climate change, and heat-related deaths among people over 65 have risen by 70% in just the last two decades.Imperial (2020): Changing temperature and rainfall across Africa could increase yellow fever deaths by up to 25% by 2050.UNEP (2023): Air pollution is the greatest environmental threat to public health globally and accounts for more than 8 million premature deaths every year.The Lancet (2021): A survey of 10,000 young people (aged 16-25 years) in 10 countries found that 59% were “very or extremely worried” about climate change, and 84% were at least moderately worried. LSE (2024): The UK experienced five heatwave periods during summer 2022 with record-breaking temperatures of over 40°C in England.NHS: During summer 2022's record breaking temperatures, England experienced an estimated 2,803 excess deaths.World Bank (2024): A changing climate could lead to excess health costs in low- and middle-income countries of at least US$21 trillion by 2050, equivalent to approximately 1.3% of their projected GDP.Thank you for listening! Please follow us on social media to join the conversation: LinkedIn | Instagram | TikTokYou can also now watch us on YouTube.Music: “Just Because Some Bad Wind Blows” by Nick Nuttall, Reptiphon Records. Available at https://nicknuttallmusic.bandcamp.com/album/just-because-some-bad-wind-blows-3Producer: Podshop StudiosHuge thanks to Siobhán Foster, a vital member of the team offering design advice, critical review and organisation that we depend upon.Stay tuned for more insightful discussions on navigating the transition away from fossil fuels to a sustainable future.

In this solo podcast episode, Dr Mike Hart provides actionable, evidence-backed strategies to improve overall circadian rhythm and consequently enhance sleep quality. He discusses the importance of a regulated sleep-wake cycle and its impact on hormone release, metabolism, immune function, and general well-being. Various methods to maintain a healthy circadian rhythm are explored, including the benefits of morning sunlight exposure, the role of blue light blocking in the evening, and the timing of meals and exercise. He also touches on the effects of caffeine and alcohol on sleep, the ideal sleep environment, and additional supportive practices like social interaction, light physical activity, and evening routines that promote relaxation.   Links: Luminette 3 Glasses Light Therapy Box (10,000 lux standard) The Paleo Solution (Book)   Show Notes: (0:00) Welcome back to the Hart2Heart Podcast with Dr. Mike Hart (02:00) Morning sunlight: The key to a healthy circadian rhythm (07:00) Evening strategies for better sleep (09:00) Exercise and movement: Timing and types (14:30) Meal timing and its impact on sleep (19:00) The role of melatonin and caffeine (20:41) “Caffeine within six hours of bed can cost you a full hour of sleep.” (25:00) Alcohol and other sleep disruptors (30:00) Optimizing your sleep environment (33:00) Pre-sleep relaxation techniques — The Hart2Heart podcast is hosted by family physician Dr. Michael Hart, who is dedicated to  cutting through the noise and uncovering the most effective strategies for optimizing health,  longevity, and peak performance. This podcast dives deep into evidence-based approaches to  hormone balance, peptides, sleep optimization, nutrition, psychedelics, supplements, exercise  protocols, leveraging sunlight light, and de-prescribing pharmaceuticals—using medications only when absolutely necessary.   Beyond health science, we tackle the intersection of public health and politics, exposing how  policy decisions shape our health landscape and what actionable steps people can take to reclaim control over their well-being.   Guests range from out-of-the-box thinking physicians such as Dr. Casey Means (author of "Good Energy") and Dr. Roger Sehult (Medcram lectures) to public health experts such as Dr. Jay Bhattacharya (Director of the National Institutes of Health (NIH) and Dr. Marty Mckary  (Commissioner of the Food and Drug Administration (FDA) and high-profile names such as  Zuby and Mark Sisson (Primal Blueprint and Primal Kitchen).   If you're ready to take control of your health and performance, this is the podcast for you. We cut through the jargon and deliver practical, no-BS advice that you can implement in your daily life, empowering you to make positive changes for your well-being.   Connect on social with Dr. Mike Hart: Instagram: @drmikehart Twitter: @drmikehart Facebook: @drmikehart  

In this edition of the Heart to Heart podcast, Dr. Mike Hart sits down with Todd Shapiro, CEO of Red Light Holland, a prominent figure in the psychedelic space. They discuss various aspects of psychedelic therapy, particularly focusing on psilocybin and its potential benefits for mental health, anxiety, and personal well-being. Todd shares his personal journey from working various jobs to becoming a key player in the psychedelic industry. They delve into recent developments in psychedelic research, the challenges of legalization, and the importance of proper protocols and responsible use. The conversation also highlights the role of microdosing and macro dosing, the differences between medicinal mushrooms and other psychedelics like MDMA and ayahuasca, and the future of psychedelic therapy.  Guest Bio and Links Todd Shapiro is the CEO of Red Light Holland, a publicly traded leader in legal psilocybin truffles and psychedelic research. A former top Canadian radio host turned mental health advocate, Todd champions safe, science-backed access to psychedelics, working with world-class researchers to advance policy reform and personal sovereignty. Follow him on X (Twitter) @ToddMShapiro Red Light Holland: http://redlight.co Third Wave: https://thethirdwave.co/microdosing-psilocybin-mushrooms-stamets-stack/?utm_source=chatgpt.com schedule35.co: https://schedule35.co/blog/paul-stamets-microdosing-protocol/?utm_source=chatgpt.com Show Notes: (00:00) Introduction to the Heart to Heart Podcast (01:30) Todd Shapiro's journey into psychedelics (03:30) Microdosing and its impact (13:30) Challenges and legalities of psychedelics (19:30) Advocacy and future of psychedelics (32:00) Concerns about unregulated psilocybin use (34:00) Regulated psilocybin sales in the Netherlands (37:00) Psilocybin administration methods (46:36) “The most clear anecdotal model of consistency… has got to be psilocybin. “ (49:30) Corporate influence on psychedelics (57:30) Global leadership in psychedelic research (59:30) Closing remarks and future prospects   --- The Hart2Heart podcast is hosted by family physician Dr. Michael Hart, who is dedicated to  cutting through the noise and uncovering the most effective strategies for optimizing health,  longevity, and peak performance. This podcast dives deep into evidence-based approaches to  hormone balance, peptides, sleep optimization, nutrition, psychedelics, supplements, exercise  protocols, leveraging sunlight light, and de-prescribing pharmaceuticals—using medications only when absolutely necessary.   Beyond health science, we tackle the intersection of public health and politics, exposing how  policy decisions shape our health landscape and what actionable steps people can take to reclaim control over their well-being.   Guests range from out-of-the-box thinking physicians such as Dr. Casey Means (author of "Good Energy") and Dr. Roger Sehult (Medcram lectures) to public health experts such as Dr. Jay Bhattacharya (Director of the National Institutes of Health (NIH) and Dr. Marty Mckary  (Commissioner of the Food and Drug Administration (FDA) and high-profile names such as  Zuby and Mark Sisson (Primal Blueprint and Primal Kitchen).   If you're ready to take control of your health and performance, this is the podcast for you. We cut through the jargon and deliver practical, no-BS advice that you can implement in your daily life, empowering you to make positive changes for your well-being.   Connect on social with Dr. Mike Hart:   Instagram: https://www.instagram.com/drmikehart/  Twitter: https://twitter.com/drmikehart   Facebook: https://www.facebook.com/MikeHartEPS/   

The mechanisms behind Alzheimer's disease have eluded scientists for decades. But a new breakthrough points to lithium as a possible explanation—not only does it occur naturally in the brain, but a deficiency causes dementia in mice. This research is one of thousands of projects that have lost funding due to President Trump's cuts to the National Institutes of Health (NIH). Host Ira Flatow speaks with Alzheimer's researcher Bruce Yankner about this new finding, and then to epidemiologist Katelyn Jetelina and immunologist Elisabeth Marnik about the country's “quiet engine of science,” the NIH.Guests: Dr. Bruce Yankner is professor of genetics and neurology at Harvard Medical School in Boston, Massachusetts.Dr. Katelyn Jetelina, epidemiologist and author of the Your Local Epidemiologist newsletter. She's based in San Diego.Dr. Elisabeth Marnik is an immunologist and Director of Science Education & Outreach at the MDI Biological Laboratory in Bar Harbor, Maine.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

In today's episode, we're diving deep into the intricate world of federal procurement, uncovering vital insights that could reshape your business strategy. Our guest, a seasoned entrepreneur, takes us on a journey through the maze of federal acquisition regulations and the diverse landscape of small business opportunities. Our discussion revolves around the power play between GSA (General Services Administration) schedules, Best in Class contracts, and small business set-asides. Our guest dissects the nuances of FAR (Federal Acquisition Regulation) Part 8, Part 16.5, and Part 19, shedding light on the discretionary nature of small business set-asides. We explore the dynamics within various government agencies, particularly spotlighting the labyrinthine structure of the National Institutes of Health (NIH) and Health and Human Services (HHS). This episode is a goldmine for entrepreneurs aiming to crack the federal procurement code, as we unravel the complexities, share practical strategies, and empower you to make informed decisions. Catch you next time on The Daily Windup for more entrepreneurial insights!

Pingkun Yan is a full professor at the Department of Biomedical Engineering at Rensselaer Polytechnic Institute (RPI), USA. Before joining RPI, he was a Senior Scientist of Philips Research working at the clinical site at the National Institutes of Health (NIH). His research focuses on translational medical imaging informatics and image-guided intervention. 

In this episode, we sit down with Mr. Wayne Berry, a Senior Procurement Analyst and Small Business Specialist at the National Institutes of Health (NIH), part of the Department of Health and Human Services. With over 15 years of experience in federal contracting, Wayne provides valuable insights into how small businesses can navigate the complex landscape of government procurement. He breaks down the differences between agencies, highlighting the contrast between Veteran Affairs and HHS, shedding light on how each agency's unique mission shapes their purchasing strategies. Wayne emphasizes that understanding not just what an agency buys, but how they buy it, is crucial for success. From GSA schedules to the nuances of the small business program, Wayne's expertise shines through as he simplifies intricate concepts for newcomers to the world of federal contracting. Join us as Wayne Berry guides us through the intricate world of government contracts, offering practical advice for small businesses seeking to make their mark. Remember, government contracts might seem like one big entity, but it's a landscape made up of diverse agencies with distinct approaches to procurement. Tune in to this episode to learn how to navigate the system and position your small business for success!

This Day in Legal History: National Security Act of 1947On this day in legal history, July 25, 1947, Congress passed the National Security Act of 1947, fundamentally reshaping the American national security infrastructure in the wake of World War II. The legislation created a unified framework to coordinate defense and intelligence operations, aiming to prevent the bureaucratic fragmentation that had plagued wartime decision-making. One of its central provisions was the formation of the National Security Council (NSC), designed to advise the president on domestic, foreign, and military policies related to national security.The Act also established the Central Intelligence Agency (CIA), which replaced the wartime Office of Strategic Services (OSS) and became the first peacetime intelligence agency tasked with gathering, analyzing, and coordinating intelligence. Additionally, it created the National Military Establishment (later renamed the Department of Defense in 1949), which consolidated the War Department and the Navy Department under a single executive authority.Within the National Military Establishment, the Act preserved the autonomy of the Army and Navy while officially creating a separate branch: the United States Air Force. It also formalized the Joint Chiefs of Staff to provide coordinated military advice to civilian leadership. These structural reforms sought to ensure more cohesive planning and execution of U.S. defense policy during a time of growing Cold War tensions.The legislation marked a profound shift in how the federal government approached global strategy, institutionalizing the military-intelligence bureaucracy that would define American power projection for decades. It also laid the legal groundwork for the modern national security state, with broad implications for executive authority, covert operations, and civil-military relations. As Cold War dynamics evolved, the institutions born from this Act became central to both overt diplomacy and covert action around the world.Ghislaine Maxwell, currently serving a 20-year sentence for aiding Jeffrey Epstein's abuse of minors, is petitioning the U.S. Supreme Court to overturn her conviction. Her legal team argues that a 2007 non-prosecution agreement made with Epstein in Florida should have shielded her and other associates from future federal prosecution. The case raises a significant legal issue: whether plea deals made by one U.S. Attorney's Office bind other federal jurisdictions. This question has divided circuit courts, increasing the chances the Supreme Court might take up the case when justices return from summer recess in late September.The Justice Department under Trump acknowledged the legal split but urged the Court to deny Maxwell's appeal, arguing that plea agreements are binding only between the negotiating parties. Maxwell's defense contends the 2007 deal's broad language promised immunity for co-conspirators nationwide, and that allowing prosecutors to renege undermines trust in the justice system. The National Association of Criminal Defense Lawyers supports her petition, citing the widespread use of plea agreements in American jurisprudence.The case unfolds amid renewed political pressure over Epstein-related disclosures, with Trump's administration walking back earlier commitments to release more records. The political sensitivity may affect the Supreme Court's willingness to get involved, especially given the presence of three Trump-appointed justices. Columbia Law professor Daniel Richman noted the unusual breadth of Epstein's original deal might make this a poor case for setting a national precedent, despite its legal significance.Amid Epstein furor, Ghislaine Maxwell seeks relief from US Supreme Court | ReutersThe Trump administration has asked the U.S. Supreme Court to allow it to implement major funding cuts to National Institutes of Health (NIH) grants, arguing the cuts align with its broader effort to dismantle federal diversity, equity, and inclusion (DEI) programs. A lower court had blocked the move in June, with U.S. District Judge William Young ruling that the cuts were unlawfully arbitrary and lacked clear justification, violating administrative law. The decision came after lawsuits from a coalition of researchers, public health groups, and 16 states led by Democratic administrations, who argued the grant cancellations were politically motivated and targeted research associated with DEI or gender identity.The administration contends that continuing to pay the $783 million in grants contradicts its policy goals. The Justice Department is also challenging the venue of the lawsuits, arguing they should have been brought in the Court of Federal Claims, which specializes in monetary claims against the federal government. The 1st U.S. Circuit Court of Appeals recently rejected that argument, refusing to pause Judge Young's ruling.Judge Young, despite being a Reagan appointee, sharply criticized the administration's actions as lacking any rational explanation and as ideologically driven. He noted that officials failed to define DEI while broadly discrediting grant-supported research without evidence. Critics, including NIH employees and scientists, have warned that the cuts undermine scientific integrity and public health.The Supreme Court, now with a 6-3 conservative majority, has been receptive to Trump administration appeals in similar cases. In April, it allowed comparable cuts to teacher training grants to proceed. The administration hopes for a similar result in this case.Trump administration asks US Supreme Court to allow NIH diversity-related cuts | ReutersGlass Lewis and Institutional Shareholder Services (ISS), two leading proxy advisory firms, have filed lawsuits against Texas over a new state law restricting their ability to advise shareholders on environmental, social, governance (ESG), and diversity, equity, and inclusion (DEI) matters. Proxy advisors provide independent recommendations to institutional investors—such as pension funds and asset managers—on how to vote on issues at shareholder meetings, including board elections, executive compensation, and corporate policies. This means their influence is significant in shaping corporate governance across markets.The new Texas law, signed by Governor Greg Abbott, requires these advisors to include disclaimers stating their recommendations may not be in the financial interest of shareholders and to back up ESG or DEI-related advice with financial analysis. Glass Lewis and ISS argue the law violates their First Amendment rights by forcing them to include government-mandated speech that contradicts their independent analysis and perspectives.Filed in federal court in Austin, the lawsuits name Attorney General Ken Paxton as the sole defendant. Both firms contend the law is politically motivated and will damage their reputations, cost them clients, and undermine shareholder oversight of corporate boards. ISS also criticized the law as serving to protect corporate executives from accountability, labeling it "anti-capitalist" and counter to shareholder interests.The legal challenge comes amid a broader rollback of corporate DEI programs nationwide and is part of a trend in Republican-led states to push back against what they see as left-leaning influence in financial decision-making. The law is scheduled to take effect on September 1, unless blocked by the court.Glass Lewis, ISS sue Texas over law limiting DEI, ESG proxy advice | ReutersThis week's closing theme is by Enrique Granados.This week's closing theme is Granados' masterwork Goyescas, Op. 11, a piano suite composed in 1911 and widely regarded as the Spanish composer's magnum opus. Subtitled Los majos enamorados (The Gallants in Love), the suite captures the spirit and elegance of 18th-century Madrid, evoking a romanticized world of passionate young lovers, elaborate dress, and melancholic reverie. Granados drew inspiration from the art of Francisco Goya, though the individual pieces are not linked directly to specific paintings. Instead, they are tonal impressions—musical vignettes steeped in the colors and textures of Goya's Spain.Goyescas is divided into two books. Granados premiered Book I on March 11, 1911, at the Palau de la Música Catalana in Barcelona, showcasing his own virtuosic pianism. Book II followed in December of that year and was first performed in Paris at the Salle Pleyel on April 2, 1914. Each movement in the suite is rich with rhythmic flair, lyrical warmth, and emotional depth, capturing the elegance of Spanish courtship rituals and the melancholy undercurrents of unfulfilled longing.The suite's most famous piece, Quejas, o La Maja y el Ruiseñor (Lament, or The Maiden and the Nightingale), would later be famously echoed in the song “Bésame Mucho.” Granados' idiomatic use of ornamentation, rubato, and folkloric rhythms set a high watermark for Spanish piano music and influenced later composers such as Albéniz and Falla. Through Goyescas, Granados created a work that is both a tribute to Goya's vision and a deeply personal expression of turn-of-the-century Spanish romanticism.Without further ado, Enrique Granados' The Gallants in Love, the third movement, El Fandango del Candil. Enjoy! This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.minimumcomp.com/subscribe

In this episode, Dr Tsen Vei Lim talks to: Dr Marilyn Piccirillo from the Department of Psychiatry at Rutgers University-New Brunswick and Drs Katherine Walukevich-Dienst and Elizabeth Lehinger from the Department of Psychiatry and Behavioral Sciences at the University of Washington School of Medicine. The interview covers their research report on the longer-term efficacy of brief, alcohol-focused personalised feedback interventions among young adults in two universities on the West coast of the US. Note for listeners: The acronym PFI is used throughout this episode, which stands for ‘personalised feedback intervention'.· What is an alcohol-focused personalised feedback intervention? [01:48]· An example of how one of these interventions would work in practice [03:03]· The importance of considering distress [03:46]· The key findings of the study [07:24]· Why ‘less is more' when it comes to alcohol interventions [12:19]· How the findings contribute to policy or practice [14:46]· The pioneers of personalised feedback interventions [17:41]About Marilyn Piccirillo: Dr Piccirillo is a licensed psychologist and an Assistant Professor in the Department of Psychiatry at Rutgers University-New Brunswick. She is also a Core Faculty member of the Rutgers Brain Health Institute and a member of the Rutgers Addiction Research Center. Dr Piccirillo uses person-centered frameworks to study motivating and maintenance factors for substance use problems, particularly for those experiencing co-occurring anxiety, trauma, and stress. She also examines how digital tools can be used to support treatment and recovery and optimise the design and delivery of treatments for substance use problems and addiction. About Katherine Walukevich-Dienst: Dr Walukevich-Dienst is a clinical psychologist and Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington. Her research focuses on developing and testing digital interventions to reduce substance use and improve mental health among young adults. She uses methods such as ecological momentary assessment to examine real-time behavior and intervention engagement. Dr Walukevich-Dienst has authored over 50 peer-reviewed publications and leads National Institutes of Health (NIH)-funded projects aimed at improving outcomes for cannabis and alcohol use through scalable, evidence-based approaches. About Elizabeth Lehinger: Dr Lehinger is an Acting Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington School of Medicine. She has two primary areas of research: 1) college student alcohol prevention, and 2) trauma recovery for individuals with co-occurring substance use disorders. Her research focuses on reward processes underlying these research areas. The authors have no conflicts of interest to disclose. Original article: Examining the longer-term efficacy of brief, alcohol-focused personalized feedback interventions for individuals with internalizing distress: Secondary analysis of a randomized controlled trial. https://doi.org/10.1111/add.70044 The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal. The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information. Hosted on Acast. See acast.com/privacy for more information.

Research funded by the federal government has been crucial in many of the defining technologies of our time: the internet, A.I., crispr, Ozempic, and the mRNA vaccines first used widely in the COVID pandemic. Between 2010 and 2019, more than 350 drugs were approved in the United States, and virtually all of them could trace their roots to the National Institutes of Health (NIH). Now this administration is endangering our health by cutting funds to academic medical centers. Moreover, there are threats to Medicaid, as well as ongoing cuts to the Centers for Disease Control (CDC). Many universities have paused hiring due to the uncertainty at the NIH and are curtailing graduate programs. Biotech investors are warning of a contraction in medical innovation. NIH grants have been terminated on ideological grounds, which have resulted in clinical trials shutting down. Global health programs worldwide have been cut. A discussion on these destructive policies on medicine in our country is needed. About the Speaker Monica Gandhi M.D., M.P.H., is a professor of medicine and associate chief in the Division of HIV, Infectious Diseases, and Global Medicine at the University of California, San Francisco (UCSF). She is also the director of the UCSF Center for AIDS Research (CFAR) and the medical director of the HIV Clinic ("Ward 86") at San Francisco General Hospital. She serves as the associate program director of the ID fellowship at UCSF. Her research focuses on HIV treatment and prevention optimization, HIV and women, adherence measurement in HIV and TB, adherence interventions, and on optimizing the use of long-acting antiretroviral therapy (ART). She is a long-standing NIH-funded researcher. Commonwealth Club World Affairs of California is a nonprofit public forum; we welcome donations made during registration to support the production of our programming. A Health & Medicine Member-led Forum program. Forums and Chapters at the Club are organized and run by volunteer programmers who are members of The Commonwealth Club, and they cover a diverse range of topics. Learn more about our Forums. Commonwealth Club World Affairs is a public forum. Any views expressed in our programs are those of the speakers and not of Commonwealth Club World Affairs. OrganizerMichael Baker  Learn more about your ad choices. Visit megaphone.fm/adchoices

Your mindset is a set of beliefs that shape how you makesense of the world and yourself. It influences how you think, feel, and behavein any given situation. It means that what you believe about yourself impactsyour success or failure. Research suggests a significant and growing number ofathletes utilize these techniques for performance enhancement and mentalwell-being. A study cited by the National Institutes of Health (NIH) found that96% of athletes surveyed reported knowledge of at least one mental technique,and a significant portion used them before competitions or for regenerationafter injuries. Furthermore, a New York Times article highlights the growingrecognition of deep breathing as a valuable tool for athletes, suggesting itsuse is not niche but rather becoming more mainstream.Jure Koscak was a professional table tennis player for 15years. During his career, he did a lot of research on sports psychology, and inthe last 15 years, after earning a Ph.D. in physical education, he hasspecialized as a mental coach for high performance. He has been working withmore than 50 professional athletes from different sports and more than 1000private clients. He is fluent in Slovenian, English, Spanish, German,Serbo-Croatian, and French. Jure is always inquiring about life and how tocontribute as much as possible so that athletes and others can strive andthrive in their arenas of life and sports. Lately, he has been using the AEQmethod to relax chronic pain and increase emotional maturity.For more information: https://www.thegenuineathlete.com/Follow: @genuine_athlete.jk

During this episode of Soundbites of the Annual Meeting, we spoke with P.J. Brooks, PhD, who is Deputy Director of the Division of Rare Diseases Research Innovation, part of the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH). In his conversation with ASGCT's Communications Committee Chair, Lynnea Olivarez, Dr. Brooks talked about: The impact of developing cell and gene therapies as platforms to treat more than one disease Projects he's involved in that are working towards the platform approach What's giving him hope right now about the future of the field Listen and subscribe to the ASGCT Podcast Network so you don't miss any episodes! Did you attend the 28th Annual Meeting? Watch all sessions on demand on the virtual meeting platform through July 18! Show your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.

In this episode of "Ask the Expert," Dr. Matthew Bellman joined Dr. GG deFiebre of SRNA to explain the basics of functional electrical stimulation (FES) and its applications. Dr. Bellman outlined how FES differs from other electrical stimulation techniques and its role in improving mobility for those with neuroimmune disorders [00:03:35]. He discussed the specific benefits of FES, including muscle strengthening and managing spasticity, and shared success stories demonstrating its impact [00:09:53]. Dr. Bellman also highlighted new developments in FES technology, particularly the integration of AI [00:33:28].Matthew Bellman, PhD is a Founder and the Chief Technology Officer for MYOLYN, Inc. Dr. Bellman is a Triple-Gator with bachelor's, master's, and doctorate degrees in mechanical engineering from the University of Florida (UF). In 2013, Dr. Bellman co-founded MYOLYN to commercialize his doctoral research on mobility assistance for people with paralysis and muscle weakness using functional electrical stimulation (FES) and robotics. In his time at MYOLYN, Dr. Bellman has been responsible for building a certified medical device quality management system, managing a team of engineers in the design and development of two Class II medical devices, obtaining grant funding from the National Institutes of Health (NIH), and growing a small business. Dr. Bellman has been awarded the Entrepreneurial Spirit Award by UF's Center for Entrepreneurship and Innovation, the O. Hugo Schuck Best Paper Award by the American Automation Control Council, and the Outstanding Young Alumnus Award by the UF Department of Mechanical and Aerospace Engineering. In 2019, Dr. Bellman secured MYOLYN's place as a finalist in the Toyota Mobility Unlimited Challenge. In addition to his role at MYOLYN, Dr. Bellman has also served as a member of the Board of Directors for NextStep Orlando's Paralysis Recovery Center and as a member of the Advisory Council for the American Bionics Project. Dr. Bellman's work has been published in high-impact scientific journals including Muscle & Nerve, IEEE Transactions on Control Systems Technology, and The Journal of NeuroEngineering and Rehabilitation, and he has been an invited guest speaker at universities around the world including UF, École Normale Supérieure (ENS) de Lyon, and the Tokyo Institute of Technology. When not at work, Dr. Bellman can be found trail running or relaxing at home with his wife and family.00:00 Introduction00:31 Meet Dr. Matthew Bellman00:52 Understanding Functional Electrical Stimulation (FES)01:30 Historical Context and Early Applications of FES03:35 How FES Works in the Body07:05 FES for Spinal Cord Damage and Neuromuscular Disorders09:53 Benefits of FES for Various Symptoms13:44 Evidence and Secondary Benefits of FES17:47 Typical FES Session and Accessibility24:06 Success Stories and Patient Feedback29:25 Barriers to FES Adoption33:28 Future Developments in FES Technology36:46 Final Thoughts and Encouragement

Substack is where I discovered Dr. MeiLan Han! I was browsing through and was pleasantly surprised to read an article, and learn that she wrote a book called, Breathing Lessons. And to top it off, she's from my home state of Michigan. I also learned the Dr. Han's book was “a passion project during the pandemic.”I'm delighted to share a conversation with Dr. MeiLan Han, one of the country's most respected voices in lung health and a tireless advocate for people living with chronic respiratory conditions.Dr. Han is a Professor of Medicine and Chief of Pulmonary and Critical Care at University of Michigan Health. She's not only cared for patients at the bedside but has devoted her career to understanding lung disease at its roots, with a special focus on chronic obstructive pulmonary disease (COPD), a condition that remains widely under-recognized and underfunded. Through her research, Dr. Han is helping to uncover how diseases like COPD affect the lungs in different ways, with the goal of making treatment more precise, more effective, and more personalized.Her journey began at the University of Washington and continued through specialized training at the University of Michigan, where she also earned a Master's degree in Biostatistics and Clinical Study Design. Today, she leads research funded by the National Institutes of Health (NIH), serves on national advisory boards for the COPD Foundation and the American Lung Association, and contributes to global guidelines that shape how lung disease is diagnosed and treated.Dr. Han also serves as Deputy Editor of the American Journal of Respiratory and Critical Care Medicine, helping to guide the direction of clinical practice and research in pulmonary medicine.If you or someone you love is living with a chronic lung condition, Dr. Han's insight is not only encouraging, it's essential. I'm so grateful to bring her voice to this platform. How many breathes do we take in a lifetime? It's fascinating to discuss and you'll hear the answer in our podcast.Lung health, do you think about it?To get her book: https://www.amazon.com/Breathing-Lessons-Doctors-Guide-Health-ebook/dp/B08X2ZFGNZ/ref=tmm_kin_swatch_0 Please like, subscribe, and comment on our podcasts!Please consider making a donation: https://thebonnellfoundation.org/donate/The Bonnell Foundation website:https://thebonnellfoundation.orgEmail us at: thebonnellfoundation@gmail.com Watch our podcasts on YouTube: https://www.youtube.com/@laurabonnell1136/featuredThanks to our sponsors:Vertex: https://www.vrtx.comViatris: https://www.viatris.com/en

Since January, the National Institutes of Health (NIH) has made sweeping cuts to science. It's hard to keep track of how many research grants were canceled, but they add up to hundreds of millions—possibly billions—of dollars of research funding lost. Some scientists, like Dr. Katie Edwards, are taking the fight to the courts. Edwards studies interpersonal violence at the University of Michigan, and she speaks with Host Flora Lichtman about why she's suing the NIH.Guest: Dr. Katie Edwards is the director of the Interpersonal Violence Research Laboratory and a professor of social work at the University of Michigan. She studies violence against marginalized communities.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

FedEx's board of directors elected R. Brad Martin as chairman following the passing of founder Fred Smith, and a decision to reduce the board's size to 12 members. The company expressed profound gratitude for Smith's vision and contributions, as Martin, previously vice chairman, now leads the audit and finance committees. Maersk has suspended services to Israel's busiest port, Haifa, and halted cargo acceptance due to ongoing conflict and safety risks from missile attacks. This decision was made prior to new missile attacks, which occurred despite reports of a potential ceasefire. The National Institutes of Health (NIH) has announced a five-year, $10 million research initiative to study the long-term health effects of the 2023 railroad derailment in East Palestine, Ohio. This marks the first large-scale coordinated federal program to address community health concerns, focusing on public health tracking, chemical exposure impacts, and multi-disciplinary communication. Also, tune into FreightWaves TV for programs like Check Call and Loaded and Rolling, and mark your calendars for upcoming events like the Enterprise Fleet Summit on July 23rd. Don't miss the Supply Chain AI Symposium on July 30th in Washington D.C., where a special ticket offer allows combining it with your F3 ticket for a reduced price. Learn more about your ad choices. Visit megaphone.fm/adchoices

FedEx's board of directors elected R. Brad Martin as chairman following the passing of founder Fred Smith, and a decision to reduce the board's size to 12 members. The company expressed profound gratitude for Smith's vision and contributions, as Martin, previously vice chairman, now leads the audit and finance committees. Maersk has suspended services to Israel's busiest port, Haifa, and halted cargo acceptance due to ongoing conflict and safety risks from missile attacks. This decision was made prior to new missile attacks, which occurred despite reports of a potential ceasefire. The National Institutes of Health (NIH) has announced a five-year, $10 million research initiative to study the long-term health effects of the 2023 railroad derailment in East Palestine, Ohio. This marks the first large-scale coordinated federal program to address community health concerns, focusing on public health tracking, chemical exposure impacts, and multi-disciplinary communication. Also, tune into FreightWaves TV for programs like Check Call and Loaded and Rolling, and mark your calendars for upcoming events like the Enterprise Fleet Summit on July 23rd. Don't miss the Supply Chain AI Symposium on July 30th in Washington D.C., where a special ticket offer allows combining it with your F3 ticket for a reduced price. Learn more about your ad choices. Visit megaphone.fm/adchoices

Tuesday, June 10th, 2025Today, Pete Hegseth has mobilized the United States Marines against American citizens in Los Angeles County; Attorney General Bonta is suing the Trump administration seeking an injunction of National Guard deployment; ABC suspends Terry Moran for a tweet calling Stephen Miller a world class hater; a former Afghan soldier was arrested by ICE in Houston and stripped of his asylum protections; Pam Bondi's brother gets TROUNCED in the DC Bar Association election; Israeli forces detain Greta Thunberg after halting the Freedom Flotilla boat carrying aid and supplies; NIH employees publish the Bethesda declaration in dissent of Trump's cuts; RFK Jr ousts the entire CDC vaccination advisory committee; and Allison and Dana deliver your Good News.Thank You, CBDistilleryUse promo code DAILYBEANS at CBDistillery.com for 25% off your purchase.  Specific product availability depends on individual state regulations.Thank You, PacagenFor an extra 25% off your order and a special gift, head to Pacagen.com/DAILYBEANS.MSW Media, Blue Wave California Victory Fund | ActBlueMarines Unleashed In LA! Trump's Authoritarian Crackdown Intensifies with Allison GillCheck out Dana's social media campaign highlighting LGBTQ+ heroes every day during Pride Month -  Dana Goldberg (@dgcomedy.bsky.social) StoriesTrump administration activates 700 Marines in Los Angeles area amid ICE protests |CBS NewsFormer Afghan soldier arrested at Houston-area home by ICE, stripped of asylum protections, attorney says | Houston Public MediaGaza-bound aid boat with Greta Thunberg on board arrives in Israel after its seizure | AP NewsRFK Jr. ousts entire CDC vaccine advisory committee | AP NewsABC Suspends Terry Moran for Calling Stephen Miller a ‘World-Class Hater' | The New York TimesPam Bondi's brother overwhelmingly defeated in heated race to lead the D.C. Bar | NPR Good Trouble: - STAND UP FOR SCIENCE - On June 9th, 2025, federal employees at the National Institutes of Health (NIH) bravely stood up for the health and safety of the American people and faithful stewardship of public resources by authoring and signing the Bethesda Declaration. Sign the Open Letter in Support of NIH Public Servants - Action NetworkProton Mail: free email account with privacy and encryptionFind Upcoming Demonstrations And ActionsSat June 14 10am – 12pm PDT AG is hosting NO KINGS Waterfront Park, San DiegoDonation link - secure.actblue.com/donate/fuelthemovement250th Anniversary of the U.S. Army Grand Military Parade and Celebration50501 MovementJune 14th Nationwide Demonstrations - NoKings.orgIndivisible.orgFederal workers - feel free to email me at fedoath@pm.me and let me know what you're going to do, or just vent. I'm always here to listen. Check out other MSW Media podcastsShows - MSW Media, Cleanup On Aisle 45 podSubscribe for free to MuellerSheWrote on SubstackThe BreakdownFrom The Good NewsNational Portrait GalleryNobody Listens to Paula PoundstoneProtesters' Rights | American Civil Liberties UnionTAKE THE PLEDGE: Don't Rank Eric or Andrew for Mayor - Action Network Reminder - you can see the pod pics if you become a Patron. The good news pics are at the bottom of the show notes of each Patreon episode! That's just one of the perks of subscribing! patreon.com/muellershewrote Federal workers - feel free to email me at fedoath@pm.me and let me know what you're going to do, or just vent. I'm always here to listen.Share your Good News or Good TroubleMSW Good News and Good Trouble Check out other MSW Media podcastshttps://mswmedia.com/shows/Subscribe for free to MuellerSheWrote on Substackhttps://muellershewrote.substack.comFollow AG and Dana on Social MediaDr. Allison Gill Substack|Muellershewrote, BlueSky|@muellershewrote , Threads|@muellershewrote, TikTok|@muellershewrote, IG|muellershewrote, Twitter|@MuellerSheWrote,Dana GoldbergTwitter|@DGComedy, IG|dgcomedy, facebook|dgcomedy, IG|dgcomedy, danagoldberg.com, BlueSky|@dgcomedyHave some good news; a confession; or a correction to share?Good News & Confessions - The Daily Beanshttps://www.dailybeanspod.com/confessional/ Listener Survey:http://survey.podtrac.com/start-survey.aspx?pubid=BffJOlI7qQcF&ver=shortFollow the Podcast on Apple:The Daily Beans on Apple PodcastsWant to support the show and get it ad-free and early?Supercasthttps://dailybeans.supercast.com/Patreon https://patreon.com/thedailybeansOr subscribe on Apple Podcasts with our affiliate linkThe Daily Beans on Apple Podcasts

My guest is Dr. Jay Bhattacharya, MD, PhD, Director of the National Institutes of Health (NIH) and Professor Emeritus of Health Policy at Stanford University. We discuss which scientific questions ought to be the priority for NIH, how to incentivize bold, innovative science especially from younger labs, how to solve the replication crisis and restore trust and transparency in science and public health, including acknowledging prior failures by the NIH. We discuss the COVID-19 pandemic and the data and sociological factors that motivated lockdowns, masking and vaccine mandates. Dr. Bhattacharya shares his views on how to resolve the vaccine–autism debate and how best to find the causes and cures for autism and chronic diseases. The topics we cover impact everyone: male, female, young and old and, given that NIH is the premier research and public health organization in the world, extend to Americans and non-Americans alike. Read the episode show notes at hubermanlab.com. Thank you to our sponsors AG1: https://drinkag1.com/huberman David: https://davidprotein.com/huberman Eight Sleep: https://eightsleep.com/huberman Levels: ⁠https://levels.link/huberman⁠ LMNT: https://drinklmnt.com/huberman Timestamps 00:00:00 Jay Bhattacharya 00:06:56 National Institutes of Health (NIH), Mission 00:09:12 Funding, Basic vs. Applied Research 00:18:22 Sponsors: David & Eight Sleep 00:21:20 Indirect Costs (IDC), Policies & Distribution 00:30:43 Taxpayer Funding, Journal Access, Public Transparency 00:38:14 Taxpayer Funding, Patents; Drug Costs in the USA vs Other Countries 00:48:50 Reducing Medication Prices; R&D, Improving Health 01:00:01 Sponsors: AG1 & Levels 01:02:55 Lowering IDC?, Endowments, Monetary Distribution, Scientific Groupthink 01:12:29 Grant Review Process, Innovation 01:21:43 R01s, Tenure, Early Career Scientists & Novel Ideas 01:31:46 Sociology of Grant Evaluation, Careerism in Science, Failures 01:39:08 “Sick Care” System, Health Needs 01:44:01 Sponsor: LMNT 01:45:33 Incentives in Science, H-Index, Replication Crisis 01:58:54 Scientists, Data Fraud, Changing Careers 02:03:59 NIH & Changing Incentive Structure, Replication, Pro-Social Behavior 02:15:26 Scientific Discovery, Careers & Changing Times, Journals & Publications 02:19:56 NIH Grants & Appeals, Under-represented Populations, DEI 02:28:58 Inductive vs Deductive Science; DEI & Grants; Young Scientists & NIH Funding 02:39:38 Grant Funding, Identity & Race; Shift in NIH Priorities 02:51:23 Public Trust & Science, COVID Pandemic, Lockdowns, Masks 03:04:41 Pandemic Mandates & Economic Inequality; Fear; Public Health & Free Speech 03:13:39 Masks, Harms, Public Health Messaging, Uniformity, Groupthink, Vaccines 03:22:48 Academic Ostracism, Public Health Messaging & Opposition 03:30:26 Culture of American Science, Discourse & Disagreement 03:36:03 Vaccines, COVID Vaccines, Benefits & Harms 03:47:05 Vaccine Mandates, Money, Public Health Messaging, Civil Liberties 03:54:52 COVID Vaccines, Long-Term Effects; Long COVID, Vaccine Injury, Flu Shots 04:06:47 Do Vaccines Cause Autism?; What Explains Rise in Autism 04:18:33 Autism & NIH; MAHA & Restructuring NIH? 04:25:47 Zero-Cost Support, YouTube, Spotify & Apple Follow & Reviews, Sponsors, YouTube Feedback, Protocols Book, Social Media, Neural Network Newsletter Disclaimer & Disclosures Learn more about your ad choices. Visit megaphone.fm/adchoices

Jamie Hartmann-Boyce and Nicola Lindson discuss emerging evidence in e-cigarette research and interview Steve Cook from the University of Michigan USA about the importance of correctly interpreting and assessing the available data. Associate Professor Jamie Hartmann-Boyce and Associate Professor Nicola Lindson discuss the new evidence in e-cigarette research and interview Dr Steven Cook from the Department of Epidemiology, School of Public Health University of Michigan and the Centre for Assessment of Tobacco Regulations, University of Michigan. In the May podcast Steve Cook discusses the methodological problems of cross-sectional data on the health effects of e-cigarette use a topic he addressed at the May 2025 EC Summit, Washington DC. Steve Cook underlines why all cross-sectional health effects studies should be interpreted with extreme caution unless they examine dose-response relationships and account for temporality and cigarette smoking confounding. Dr Cook emphasises the importance of other information such as smoking histories and health histories and the importance of developing a best practice to ensure that we minimize the risks associated with spurious association and maximise predictive accuracy. Steven Cook receives National Institute for Health (NIH) and Food and Drug Administration's (FDA) Center for Tobacco Products (CTP) funding. This is not deemed a conflict of interest. EC Summit, Washington DC: https://www.e-cigarette-summit.com/program-2025/ Recent paper: 10.1016/j.isci.2025.111985 This podcast is a companion to the electronic cigarettes Cochrane living systematic review and Interventions for quitting vaping review and shares the evidence from the monthly searches. Our search for the EC for smoking cessation review carried out on 1st May 2025 found 1 ongoing (NCT06922617) and 1 linked study (DOI: 10.1101/2025.02.17.25322409). Our search for our interventions for quitting vaping review up to 1st May 2025 found 1 new (DOI 10.1001/jama.2025.3810) and 4 ongoing studies (DOI 10.2196/71961, KCT0010346, NCT06909500, NCT06929520). For further details see our webpage under 'Monthly search findings': https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1 For more information on the full Cochrane review of E-cigarettes for smoking cessation updated in January 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010216.pub9/full For more information on the full Cochrane review of Interventions for quitting vaping published in January 2025 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD016058.pub2/full This podcast is supported by Cancer Research UK.

"It is a scientific fact that these macaques, like all other primates, including humans, are communicating. They communicate in much the same way we do - facial expressions, vocalizations, body postures, those kinds of things." - Jeff Kerr Jeff Kerr is PETA foundations Chief Legal Officer. I asked him to come on the show to talk about one of PETA's current lawsuits against the National Institutes of Health (NIH) and Nathional Institute of Mental Health (NIMH). PETA is arguing that the monkeys being tested on in a government run facility are capable of communication (or “are communicating”). And that we have a constitutional right under the First Amendment to receive their communications. This could be a game changer in allowing us to see what's really going on in labs that are funded by taxpayer money, and which have so far been censored from public view. PETA's lawsuit follows years of NIH's attempts to deny Freedom of Information requests banning PETA executives from its campus and illegally censoring animal advocates' speech on NIH's public social media pages. Through the lawsuit, PETA is seeking a live audio-visual feed to see and hear real-time communications from the macaques who have been kept isolated, used in fear experiments, and had posts cemented into their heads. Anthropologists and other scientists have studied macaque and other primate communications for decades and know that the monkeys communicate effectively and intentionally through lip smacking, fear grimaces, body language, and various cries and sounds—all of which constitute speech under the law. Primatologists can analyze that speech on a deeper level to share their stories with the world.

Vaccination is one of the best ways to prevent diseases. Over the past 50 years, essential vaccines saved at least 154 million lives (1). During the same period, vaccination has reduced infant deaths by 40%. Together with governments, vaccine manufacturers, scientists and medical experts, WHO's vaccine safety program is constantly helping monitor the safety of vaccines. This helps ensure that vaccines are safe for you and your family. ​In the United States, a number of safeguards are required by law to help ensure that the vaccines we receive are safe. Because vaccines are given to millions of healthy people—including children—to prevent serious diseases, they're held to very high safety standards. Every authorized or approved vaccine goes through safety testing, including: Testing and evaluation of the vaccine before it's licensed by the Food and Drug Administration (FDA) and recommended for use by the Centers for Disease Control and Prevention (CDC) Monitoring the vaccine's safety after it is recommended for infants, children, or adults ​ Before a vaccine is ever recommended for use, it's tested in labs. This process can take several years. FDA uses the information from these tests to decide whether to test the vaccine with people. During a clinical trial, a vaccine is tested on people who volunteer to get vaccinated. Clinical trials usually start with 20 to 100 volunteers, but eventually include thousands of volunteers. These tests can take several years and answer important questions like: Is the vaccine safe? What dose (amount) works best? How does the immune system react to it? Throughout the process, FDA works closely with the company producing the vaccine to evaluate the vaccine's safety and effectiveness. All safety concerns must be addressed before FDA licenses or authorizes a vaccine. ​Once a vaccine is approved or authorized, it continues to be tested. The company that makes the vaccine tests batches to make sure the vaccine is: Potent (It works like it's supposed to) Pure (Certain ingredients used during production have been removed) Sterile (It doesn't have any outside germs) FDA reviews the results of these tests and inspects the factories where the vaccine is made. This helps make sure the vaccines meet standards for both quality and safety. ​Once a vaccine is recommended for use, FDA, CDC, and other federal agencies continue to monitor its safety. ​The United States has one of the most advanced systems in the world for tracking vaccine safety. Each of the systems below supplies a different type of data for researchers to analyze. Together, they help provide a full picture of vaccine safety. Vaccine Adverse Events Reporting System (VAERS): VAERS is an early warning system managed by CDC and FDA that is designed to find possible vaccine safety issues. Patients, health care professionals, vaccine companies, and others can use VAERS to report side effects that happen after a patient received a vaccine. Some side effects might be related to vaccination while others might be a coincidence (happen by chance). VAERS helps track unusual or unexpected patterns of reporting that could mean there's a possible vaccine safety issue that needs further evaluation. The Vaccine Safety Datalink (VSD): VSD is a collaboration between CDC and several health care organizations across the nation. VSD uses databases of medical records to track vaccine safety and do research in large populations. By using medical records instead of self-reports, VSD can quickly study and compare data to find out if reported side effects are linked to a vaccine. Post-licensure Rapid Immunization Safety Monitoring System (PRISM), links to an external website, opens in a new tab: PRISM is part of the Sentinel Initiative, which is FDA's national system for monitoring medical products after they're licensed for use. PRISM focuses on vaccine safety—it uses a database of health insurance claims to identify and evaluate possible safety issues for licensed vaccines. Clinical Immunization Safety Assessment Project (CISA): CISA is a collaboration between CDC and a national network of vaccine safety experts from medical research centers. CISA does clinical vaccine safety research and—at the request of providers—evaluates complex cases of possible vaccine side effects in specific patients. Biologics Effectiveness and Safety (BEST) System: A system that uses multiple data sources and rapid queries to detect or evaluate adverse events or study specific safety questions. Additional research and testing: The Department of Defense (DoD), the U.S. Department of Veterans Affairs (VA), and the Indian Health Service (IHS) have systems to monitor vaccine safety and do vaccine safety research. The National Institutes of Health (NIH) and the Office of Infectious Disease and HIV/AIDS Policy (OIDP) also support ongoing research on vaccines and vaccine safety. During emergencies, such as the COVID-19 pandemic, additional safety activities are utilized to help evaluate the data in quickly and with special populations. For example, a new smartphone tool called V-safe uses text messaging and surveys to check in with COVID-19 vaccine recipients after vaccination.  (CREDITS)   

My guest is Dr. Christopher Gardner, Ph.D., professor of medicine and director of nutrition studies at Stanford. He is known for his pioneering research on the impact of dietary interventions on weight loss and health. We compare ketogenic, vegetarian, vegan and omnivorous diets—and why there is no one-size-fits-all approach. All agree, however, that eliminating or dramatically reducing processed foods is best for health. We discuss the protein needs controversy; plant vs. animal proteins; the importance of fiber and low-sugar fermented foods for gut health and inflammation; and how diet affects gene expression. We also review food allergies—including gluten, wheat, dairy and soy—as well as raw dairy. The episode offers data-supported advice for healthier eating. Read the episode show notes at hubermanlab.com. Thank you to our sponsors AG1: https://drinkag1.com/huberman Eight Sleep: https://eightsleep.com/huberman Mateina: https://drinkmateina.com/huberman BetterHelp: https://betterhelp.com/huberman LMNT: https://drinklmnt.com/huberman Levels: https://levelshealth.com/huberman Timestamps 00:00:00 Christopher Gardner 00:02:32 Is there a Best Diet?, Individual Needs, Geography & Diet, Lactose 00:11:02 Sponsors: Eight Sleep & Mateina 00:13:49 Raw Milk, Lactose Intolerance 00:20:33 Wheat Allergies, Gluten Intolerance; Celiac Disease 00:25:12 Processed Foods, Food Dyes, Research Outcomes, NOVA Classification, GRAS 00:33:44 Processed Foods, Economic & Time Considerations, US vs European Products 00:39:59 Food Industry Funding, Investigator Influence, Equipoise, Transparency 00:50:10 Sponsors: AG1 & BetterHelp 00:53:11 Industry Funding, National Institute of Health (NIH) 00:56:41 Whole Food, Plant-Based Diet; Diet Comparison, DIETFITS, A TO Z Study 01:10:24 Nutrition Naming, Omnivore, Meat, Animal Feeding Operations (CAFO) 01:17:14 Transforming American Diet; Taste, Health & Environment 01:22:26 Sponsor: LMNT 01:23:43 Food Preparation, Chefs, Improve School Food 01:29:54 Scalability, Mega-Farms, Small Farm & Farmer Loss 01:34:25 Protein Requirements, Dietary Protein Recommendations, Standard Deviations 01:45:33 Protein & Storage 01:52:12 Plants & Complete Proteins?, Legumes, Bioavailability 02:01:58 Sponsor: Levels 02:03:17 Beyond Meat, Impossible Meat, Ingredients, Sourcing Meat, Salt 02:09:18 Vegan vs Omnivore Diet, Twin Study, Cardiometabolic Markers, Genes, Microbiome 02:20:24 Health Science Communication, DEXA; “Protein Flip” Diet; Food Patterns, Caloric Intake 02:31:29 Microbiome, Inflammation, Fiber, Tool: Low-Sugar, Fermented Food 02:45:32 Acknowledgements 02:47:55 Zero-Cost Support, YouTube, Spotify & Apple Follow & Reviews, Sponsors, YouTube Feedback, Protocols Book, Social Media, Neural Network Newsletter Disclaimer & Disclosures

BrainStorm wants to hear from you! Send us a text.in this episode of the "BrainStorm" by UsAgainstAlzheimer's, George Vradenburg, Co-founder and Chairman of UsAgainstAlzheimer's, and Russ Paulsen, the organization's Chief Operating Officer, discuss the impact of the Trump administration's policies on Alzheimer's research with host Meryl Comer. The conversation highlights the systematic dismantling of the National Institutes of Health (NIH) and other critical agencies, which threatens to undermine Alzheimer's research and public health. Vradenburg and Paulsen express concerns about the lack of transparency in the reorganization and the potential negative effects on drug reviews and approvals due to significant cuts at the FDA. They highlight the importance of protecting key programs that support seniors and the potential global impact of these policy changes. Despite the challenges, both Paulsen and Vradenburg are optimism about scientific advances in diagnosing and treating Alzheimer's, including the development of blood tests and new treatments. Hear the call to action for listeners to advocate for continued support for Alzheimer's research and to contact their members of Congress to ensure that funding remains a priority. This is a must listen episode!  This episode is sponsored by Genentech.Support the show

On this episode of the podcast, Justin Goodman, Senior Vice President for Advocacy and Public Policy at White Coat Waste Project (WCW) discussed his organization's efforts to end animal testing, particularly at the National Institutes of Health (NIH). Since 2016, WCW have exposed and fought against cruel experiments, including the NIH's septic shock experiments on Beagles, which killed over 2,100 dogs over 40 years. Goodman highlighted the bipartisan support from lawmakers like Senators Rand Paul and Joni Ernst, and the significant progress made under the Trump Administration. He criticized PETA for not contributing significantly to these efforts and emphasized the need for continued advocacy to end federal funding for animal testing.You can learn more or donate to White Coat Waste Project by visiting their website: WhiteCoatWaste.org. You can also follow Justin Goodman on X: @JustinRGoodman.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Joseph Ladapo is a Nigerian-American physician and health policy researcher currently serving as the Surgeon General of Florida since 2021. Born in Nigeria, he immigrated to the United States at the age of 5 with his family when his father, a microbiologist, came to continue his studies. Dr. Ladapo completed his undergraduate studies at Wake Forest University, where he was a decathlete and captain of the varsity track and field team. He then went on to earn his MD from Harvard Medical School and a PhD in Health Policy from Harvard Graduate School of Arts and Sciences. He completed his clinical training in internal medicine. Throughout his career, Dr. Ladapo has held various academic positions. He served as a faculty member in the Department of Population Health at NYU School of Medicine and as a Staff Fellow at the U.S. Food and Drug Administration (FDA). Prior to his current role, he was an Associate Professor at the David Geffen School of Medicine at UCLA. Dr. Ladapo's research focuses on clinical trial interventions and reducing the population burden of cardiovascular disease. His work has been funded by the National Institutes of Health (NIH) and the Robert Wood Johnson Foundation, and his studies have been published in leading medical journals. In recent years, Dr. Ladapo has gained prominence for his bold stance on COVID-19 mitigation measures, in which he opposed mask and vaccine mandates, questioned the safety of COVID-19 vaccines, and approved alternative treatments. Currently, Dr. Ladapo serves as a Professor of Medicine at the University of Florida College of Medicine in addition to his role as Florida's Surgeon General. He is married and has three young children.

Your gut health impacts everything. You need to understand insights to take good care of it. This week's guest is Dr. Aisha Pandor, Co-Founder & CEO of Pandora Health, a health tech company leveraging AI and gut microbiome intelligence to help women manage chronic health conditions. Hear how the gut-driven, AI-powered platform works, a sneak peek at the user journey, the role of AI in personalizing wellness plans, how they're keeping a patient-centric approach, as well as her advice for fellow aspiring entrepreneurs. Tune in to this episode to improve gut health for women!   Learn more: Dr. Aisha Pandor Pandora Health Pandora Health LinkedIn   Today's Hot Flash and other stats from: National Institutes of Health (NIH)

In this episode, Steven breaks down a tumultuous week in public health and healthcare policy — from a growing trade war with China and its potential impact on medical imports, to the elimination of a vital pain research office at the National Institutes of Health (NIH). He also unpacks the mixed messaging from HHS Secretary RFK Jr. on vaccines, including unchecked claims about measles treatments. Tune in for a timely and important public health update. Among the highlights in this episode: 00:57: Steven unpacks the wave of new tariffs, and how they might impact healthcare costs and access 04:14: Steven explains the implications for patients if pharmaceutical products and medical devices face future tariffs 06:45: Steven discusses the shutdown of the NIH’s Office of Pain Policy and Planning, and how it could stall research and support for people living with chronic pain 08:23: Steven addresses RFK Jr.'s shifting statements on vaccines in response to a second measles-related death in Texas 09:12: Steven raises concern over RFK Jr.’s promotion of unproven treatments for measles, including cod liver oil and vitamin A 10:25: Steven explains why these alternative therapies can be harmful and misleading, especially when used instead of scientifically validated treatments 11:42: Steven gives a shout-out to GHLF’s Healthcare Matters podcast episode featuring former FDA Commissioner Peter Pitts, exploring deeper implications of agency cuts. You can listen to the full episode here: https://ghlf.org/healthcarematters/#episode55 12:10: Steven announces the launch of the new Lupus Help Center at www.lupushelpcenter.org — a go-to resource for people living with lupus Contact Our Host Steven Newmark, Chief of Policy at GHLF: snewmark@ghlf.org A podcast episode produced by Ben Blanc, Director, Digital Production and Engagement at GHLF. We want to hear what you think. Send your comments in the form of an email, video, or audio clip of yourself to podcasts@ghlf.org Catch up on all our episodes on our website or on your favorite podcast channel.See omnystudio.com/listener for privacy information.

Send us a textIt's been a dire year for global health. Almost as soon as he took office as president of the United States, Donald Trump said he would withdraw the country from membership in the World Health Organization (WHO), he fired almost everyone at the U.S. Agency for International Development (USAID), and slashed staffing and budgets at U.S. health agencies such as the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC). The United States government also says it plans to end funding for Gavi, the Vaccine Alliance, and has cut some funding for the United Nations World Food Program's efforts to feed millions of people in 14 countries.Before Trump, the United States was the largest donor to global health in the world, contributing about US$12 billion in funding. That's less than 1 percent of the United States federal budget. But the new administration claimed these efforts were wasteful, did not serve the country's interests, and cost too much. It's not clear who can or will fill the gaps.“I think we are going through a very dark time,” says Dr. Ramanan Laxminarayan, founder and president of the One Health Trust. But Dr. Laxminarayan, an epidemiologist and economist, does see some hope. He doubts the United States will permanently end its robust support of global health and he sees opportunities for organizations such as WHO to streamline and become more efficient.Listen as he chats with One World, One Health host Maggie Fox about the immediate effects of the startling new United States government policies and how he sees things shaking out in the long term.

On Tuesday, April 8, unions, unionized federal workers, and their supporters around the country mobilized for a national “Kill the Cuts” day of action to protest the Trump administration's cuts to life-saving research, healthcare, and education programs. As organizers stated on the Kill The Cuts website,  "By cutting funds to lifesaving research and medical care, the Trump administration is abandoning families who are suffering and costing taxpayers billions of dollars. These cuts are dangerous to our health, and dangerous to our economy. On Tuesday, April 8th, 2025 workers across the country are standing up and demanding NO cuts to education and life-saving research." In this on-the-ground edition of Working People, we take you to the front lines of the Kill the Cuts rally that took place in Washington DC, and we speak with workers and union representatives whose lives and work have already been affected by these cuts.Speakers include: Margaret Cook, Vice President of the Public, Healthcare, and Education Workers sector of the Communications Workers of America (CWA); Matt Brown, Recording Secretary of NIH Fellows United (United Auto Workers Local 2750); Rakshita Balaji, a post-baccalaureate researcher at the National Institutes of Health (NIH); and Amanda Dykema, shop steward for American Federation of State, County, and Municipal Employees (AFSCME) Local 1072 at the University of Maryland, College Park.Additional links/info: Kill the Cuts website NIH Fellows United website Maximillian Alvarez, Working People / The Real News Network, “What's really behind Trump's war on federal unions?” Jocelyn Kaiser, Science, “NIH under orders to cancel $2.6 billion in contracts” Permanent links below… Leave us a voicemail and we might play it on the show! Labor Radio / Podcast Network website, Facebook page, and Twitter page In These Times website, Facebook page, and Twitter page The Real News Network website, YouTube channel, podcast feeds, Facebook page, and Twitter page Featured Music… Jules Taylor, “Working People” Theme Song Studio Production: Maximillian Alvarez Post-Production: Jules Taylor

On Tuesday, April 8, unions, unionized federal workers, and their supporters around the country mobilized for a national “Kill the Cuts” day of action to protest the Trump administration's cuts to life-saving research, healthcare, and education programs. As organizers stated on the Kill The Cuts website,  "By cutting funds to lifesaving research and medical care, the Trump administration is abandoning families who are suffering and costing taxpayers billions of dollars. These cuts are dangerous to our health, and dangerous to our economy. On Tuesday, April 8th, 2025 workers across the country are standing up and demanding NO cuts to education and life-saving research." In this on-the-ground edition of Working People, we take you to the front lines of the Kill the Cuts rally that took place in Washington DC, and we speak with workers and union representatives whose lives and work have already been affected by these cuts.Speakers include: Margaret Cook, Vice President of the Public, Healthcare, and Education Workers sector of the Communications Workers of America (CWA); Matt Brown, Recording Secretary of NIH Fellows United (United Auto Workers Local 2750); Rakshita Balaji, a post-baccalaureate researcher at the National Institutes of Health (NIH); and Amanda Dykema, shop steward for American Federation of State, County, and Municipal Employees (AFSCME) Local 1072 at the University of Maryland, College Park.Additional links/info:Kill the Cuts websiteNIH Fellows United websiteMaximillian Alvarez, Working People / The Real News Network, “What's really behind Trump's war on federal unions?”Jocelyn Kaiser, Science, “NIH under orders to cancel $2.6 billion in contracts”Permanent links below…Leave us a voicemail and we might play it on the show!Labor Radio / Podcast Network website, Facebook page, and Twitter pageIn These Times website, Facebook page, and Twitter pageThe Real News Network website, YouTube channel, podcast feeds, Facebook page, and Twitter pageFeatured Music…Jules Taylor, “Working People” Theme SongStudio Production: Maximillian AlvarezPost-Production: Jules TaylorBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-real-news-podcast--2952221/support.

When you think of workplace wellness, you may picture gym memberships and yoga mats. But joy, empathy, and inclusion also create a healthy and high-performing workplace culture! We need to reimagine what wellness means!Today, Misha Safran, shares how empathy intersects with inclusion to foster innovation and equity. We also discuss how to reframe the misconceptions about empathy that exist in high-pressure workplaces. With brilliant mindset shifts and practical tips, she shares how leaders can model empathy without feeling performative, and how to navigate conflict using empathy and emotional intelligence. Misha shares the four elements of joy and why you can be more successful when you embrace them so your team can break free from chaos and transform that energy into creativity, problem-solving, and success. To access the episode transcript, please search for the episode title at www.TheEmpathyEdge.comKey Takeaways:Empathy is love, care, and concern - not agreement. It's having conversations, it's listening to know what's going on, and it's having healthy boundaries.Empathy before accusation.Empathy might look different depending on personality - it doesn't have to mean being touchy-feely or crying on the floor with your employees.Especially in conflict, urgency causes chaos - slow down, take a pause, take a breath, and respond, don't react. Slow down to build up. "Ask questions for the person in front of you to grow, not for you to know." — Misha SafranFrom Our Partner:SparkEffect partners with organizations to unlock the full potential of their greatest asset: their people. Through their tailored assessments and expert coaching at every level, SparkEffect helps organizations manage change, sustain growth, and chart a path to a brighter future.Go to sparkeffect.com/edge now and download your complimentary Professional and Organizational Alignment Review today.About Misha Safran, Founder, Center for Empathy and Emotional IntelligenceMisha Safran, an engaging keynote speaker and author, holds a Professional Coaching Certification (PCC) from the International Coaching Federation (ICF). She is the founder of CEEQ, the Center for Empathy and Emotional Intelligence, LLC, and in 2022 was honored with the CEO Award from the National Institute of Health (NIH) for her impactful work on a DEIA training team.With infectious positivity, intuitive insights, and deep empathy, Misha creates safe spaces for individuals and teams to navigate discomfort while building essential skills. Her unique ability to support organizations in transforming conflict into connection, collaboration, and currency inspires communities to thrive, celebrate achievements, and foster renewed enthusiasm for collective work.Misha's passion lies in empowering people to reset their mindset, unlocking renewed energy, improved problem-solving, heightened creativity, and more thoughtful communication. She has dedicated her career to cultivating inclusive, sustainable relationships and fostering environments where everyone can succeed.Connect with Misha:CEEQ: ceeq.orgLinkedIn: linkedin.com/in/misha-safranFacebook: facebook.com/CEEQempathyInstagram: instagram.com/mishasafranWorkplace Wellness Program: Laughter to Joy Wellness Experience for Connection, Collaboration, and Sustainable Success - Schedule a consultation: misha@ceeq.orgBook: A Teacher's Companion: Centering Empathy & Emotional Well-Being for Yourself and Your Students and bonus package for schools! Connect with Maria:Get Maria's books on empathy: Red-Slice.com/booksLearn more about Maria's work: Red-Slice.comHire Maria to speak: Red-Slice.com/Speaker-Maria-RossTake the LinkedIn Learning Course! Leading with EmpathyLinkedIn: Maria RossInstagram: @redslicemariaFacebook: Red SliceThreads: @redslicemariaWe would love to get your thoughts on the show! Please click https://bit.ly/edge-feedback to take this 5-minute survey, thanks!

Governor Patrick Morrisey of West Virginia discusses his initiatives to improve health, including the "Four Pillars of Healthy West Virginia" focusing on food cleanliness, work incentives, daily exercise, and healthy food choices. He highlights the "Mountaineer Mile" initiative, encouraging daily walks, and the "SNAP" program's shift to promote nutritious food. Morrisey also emphasizes West Virginia's microgrid movement, aiming to attract data centers and reduce income taxes through new developments. Additionally, he mentions the state's ban on Red Dye Number 3 in food and the Riley Gaines Act, which defines sex-based terms in sports, protecting women's sports.Additionally, Utah State Representative Trevor Lee sheds light on the state's progressive legislative actions, including a groundbreaking bill to ban certain flags from government buildings and the push for gold as a transactional currency.Finally, Dr. Isaiah Hankel, a former NIH-funded researcher and CEO of Overqualified.com. Dr. Hankel shares his insights on the corruption and lack of accountability within the National Institutes of Health (NIH), discussing how research priorities often overshadow human safety. He highlights alarming statistics about the reproducibility of scientific studies and the opaque nature of funding and oversight.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this Podcast Extra, we hear the latest on how decisions by the Trump administration are affecting science in the US. Most recently, a purge of National Institutes of Health (NIH) leadership has seen the chiefs of multiple institutes and centres removed from their posts.Plus, after cancelling nearly all NIH projects studying transgender health, the White House has directed the agency to focus on studying “regret” after a person transitions to align their body with their gender identity.News: ‘One of the darkest days': NIH purges agency leadership amid mass layoffsNews: Exclusive: Trump White House directs NIH to study ‘regret' after transgender people transitionNews: Are the Trump team's actions affecting your research? How to contact Nature Hosted on Acast. See acast.com/privacy for more information.

Social Determinants of Health, or SDOH, are a buzzword these days—but often little more. We acknowledge their importance, but actual progress on capture (and subsequent patient support) has been slow. To be fair real barriers including technological limitations and limited financial incentives stand in the way. But my current guest understands better than most the major role SDOH play in patient health. He and his organization have developed a digital tool to facilitate capture and improve the lives of patients in their community. They're making a difference. Dr. Pablo Buitron de la Vega is Assistant Professor of Medicine, Medical Director, Preventive Medicine Residency, and Clinician Lead for the THRIVE Social Determinants of Health Program at Boston Medical Center / Boston University School of Medicine. A native of Ecuador, he's made SDOH his mission. On this show we cover: Dr. de la Vega's long journey from Ecuador to U.S. physician, the obstacles he overcame, and how the experience shaped his mission as a provider Defining SDOH and common examples in his line of work as a Boston physician Basics of capture in ICD-10 and what makes SDOH difficult to collect Boston Medical Center's SDOH capture tool, THRIVE: What it does, tangible benefits, and how your organization can get access Low-tech strategies for SDOH capture you can implement today Dr. de la Vega's National Institutes of Health (NIH) grant to develop a triage tool to help address patients' unmet social needs

Today's guest is Dan Elton, a Staff Scientist at the National Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH). Dan returns to the program to explore how AI is advancing genetic research, from protein engineering to gene editing and risk prediction. One of the most significant breakthroughs in this space is AlphaFold, DeepMind's AI model that predicts protein structures with unprecedented accuracy. While it does not analyze genetic sequences directly, its ability to model protein folding is transforming drug development and protein engineering. Dan also discusses the potential for AI to improve polygenic risk prediction, where machine learning models are being applied to assess disease risk based on genetic markers. If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

My guest is Dr. Chris Palmer, M.D., a board-certified psychiatrist and professor at Harvard Medical School. He explains how specific nutrition, exercise, supplement-based, and other factors can improve mitochondrial health and thereby provide relief from adult and childhood ADHD, bipolar disorder, schizophrenia, and symptoms of autism. We discuss mitochondrial biology, whether vaccines can impact inflammation and mitochondrial health, and the potential ramifications. We also review creatine, methylene blue, and urolithin A, as well as the role of B vitamins and iron in treating depression. By the end of this episode, you will understand the powerful link between metabolic health and mental health, and the lifestyle, dietary, and other factors you can leverage to help overcome common mental health challenges and disorders. Read the episode show notes at hubermanlab.com. Thank you to our sponsors AG1: https://drinkag1.com/huberman Our Place: https://fromourplace.com/huberman LMNT: https://drinklmnt.com/huberman Eight Sleep: https://eightsleep.com/huberman Function: https://functionhealth.com/huberman Timestamps 00:00:00 Dr. Chris Palmer 00:02:15 Integrating Metabolic, Mental & Physical Health; Childhood Trauma & Risk 00:10:46 Sponsors: Our Place & LMNT 00:13:44 Depression Causes, Molecule Model?, Neuroplasticity?; Metabolism 00:22:20 Mitochondrial Functions, Stress Response, Mental Health 00:31:09 Sponsors: AG1 & Eight Sleep 00:33:59 Mitochondrial Health & 6 Pillars of Lifestyle Medicine 00:39:38 Stimulants, Mitochondria, Dopamine; Alcohol 00:45:47 Nicotine; Substance Use, Metabolic Health & Disease 00:52:23 Children, Energy & Metabolic Function; Diseases of Aging & Mental Disorders 00:59:18 Sponsor: Function 01:01:06 Diet & Metabolism; Ultra-Processed Foods, Additives, GRAS 01:09:30 Rebellious Spirit, Ultra-Processed Foods & Food Industry Funding 01:19:14 Ketogenic Diet, Epilepsy, Schizophrenia, Bipolar 01:22:52 Ketogenic Diet, Fasting & Mitochondria; Gut Microbiome, Brain Metabolism 01:30:06 Low-Fat Diets; Tool: Occasional Fasts; Ketogenic Diet; Intermittent Fasting 01:38:40 Nutrition Research, Food Industry Lobbyists; Ultra-Processed Foods, Addiction 01:46:55 Creatine & Mitochondrial Health 01:52:34 Methylene Blue & Mitochondria; Serotonin Syndrome 02:02:58 Urolithin A, Mitochondria Function; Supplements & Appropriate Use 02:11:14 Vitamin Deficiencies, Iron Deficiency 02:16:06 Vitamin B12 & Folate Deficiency, Autoimmune Disorders 02:24:48 Mental Illness & Root Causes 02:29:02 Vaccines, Inflammation, Mitochondria, Autism 02:39:17 Neurodevelopmental Disorder Onset & Follow-Up 02:45:31 Vaccines, Autism, Future Research; Mother Obesity & Diabetes 02:51:23 Father Obesity & Autism; Poor Metabolic Health, Blood Biomarkers 02:56:44 Assessing Metabolic Health & Biomarkers; National Institutes of Health (NIH) 03:02:59 Future Directions, Bridging Mental & Physical Health 03:09:27 Zero-Cost Support, YouTube, Spotify & Apple Follow & Reviews, YouTube Feedback, Protocols Book, Social Media, Neural Network Newsletter Disclaimer & Disclosures

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Learning more about the FDA letter sent to Dexcom, news from ATTD including a bihormonal pump from a Dutch company, time in tight range update, more studies about using insulin and GLP-1 medications, eating chili to prevent gestational diabetes (really!) and more..  Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Our top story this week: Dexcom Dive Brief: A warning letter posted Tuesday by the Food and Drug Administration revealed quality control issues with Dexcom's continuous glucose monitors. The FDA raised concerns with a design change to a component used in the resistance layer of Dexcom's sensors. The sensors with the new component were less accurate than those with the original component, according to the warning letter. Dexcom has ceased distribution of G7 sensors with the component, but the company's response did not address affected G6 sensors. J.P. Morgan analyst Robbie Marcus wrote in a research note Tuesday that the letter concerns a chemical compound that the sensor wire is dipped in. Dexcom began producing the compound internally to add redundancy to its supply chain.   Dive Insight: Dexcom Chief Operating Officer Jake Leach said in an interview with MedTech Dive last week that the company does not expect the warning letter to affect future product approvals, including a 15-day version of its G7 CGM, and there's no need yet to recall products. Dexcom has submitted the device to the FDA and anticipates a launch in the second half of the year.   Marcus, after speaking to company leadership and a quality control expert, wrote that many of the issues outlined in the letter could be addressed quickly. He added that the warning letter could explain minor delays in approval to the 15-day sensor, but Dexcom is still within the 90-day window for a 510(k) submission.   “While there's always a risk this could impede future product approvals,” Marcus wrote, “we do not expect this to materially delay the 15 day G7 sensor approval.”   The warning letter followed an FDA inspection last year of Dexcom's facilities in San Diego and Mesa, Arizona. Marcus wrote that after the FDA requested additional information and a separate 510(k), Dexcom stopped in-sourcing the compound and reverted back to the external supplier.   Dexcom's devices were misbranded because the company did not submit a premarket notification to the FDA before making major changes to the sensors, according to the warning letter. The sensors with the changed coating “cause higher risks for users who rely on the sensors to dose insulin or make other diabetes treatment decisions,” the letter said.     The FDA raised other concerns in the warning letter, including procedures to monitor the glucose and acetaminophen concentrations used in testing of the G6 and G7 CGMs. The FDA also cited problems with Dexcom's handling last year of a deficiency in its G6 sensors with dissolved oxygen content values, a key input for measuring blood glucose levels. https://www.medtechdive.com/news/dexcom-warning-letter-cgm-coating-change/743597/ XX Lots of studies and info out of the recent ATTD conference. One highlight that has been sort of under the radar: a Dutch company has been using a Bihormonal fully closed-loop system for the treatment of type 1 diabetes in the real world. This is a company called Inreda (in-RAY-duh). The Inreda AP® is an automatic system (closed loop) and independently regulates the blood glucose level by administering insulin and glucagon. The AP5 is certified in Europe and is being used in multiple studies and projects. The AP®6 is currently under development. https://www.inredadiabetic.nl/en/discover-the-ap/ https://pubmed.ncbi.nlm.nih.gov/38443309/ XX Let's talk about time in tight range. If you follow me and diabetes connections on social, you likely saw a video I made about this – it blew up last week. If not.. time in range has been a metric for a short while now.. in 2019 there was a consensus report advising a goal of 70% of time in the 70-180 mg/dL range for most people with type 1 diabetes (T1D) and type 2 diabetes (T2D), with modifications for certain subgroups. Recently we've been hearing more about 70-140 mg/dL — for longer periods as “time in tight range (TiTR).” At ATTD there was more talk about calling that range TING, or “time in normal glycemia.     There's a great writeup that I'll link up from the great Miriam Tucker on Medscape about a debate that happened at ATTD. On March 22, 2025, two endocrinologists debated this question at the Advanced Technologies & Treatments for Diabetes (ATTD) 2025. Anders L. Carlson, MD, medical director of the International Diabetes Center (IDC), Minneapolis, took the positive side, while Jeremy Pettus, MD, assistant professor of medicine at the University of California San Diego, who lives with T1D himself, argued that it's too soon.   https://www.medscape.com/viewarticle/should-time-tight-range-be-primary-diabetes-goal-2025a100073q?form=fpf   XX Sequel Med Tech announces its twist pump will be firs paired with Abbott's FreeStyle Libre 3 Plus. The twist has FDA approval for ages 6 and up and is set to begin its commercial launch by the end of June. The pump—designed by inventor Dean Kamen's Deka Research & Development—also incorporates the FDA-cleared Tidepool Loop software program, to record CGM blood sugar readings, make predictions based on trends and adjust its background insulin levels accordingly. https://www.fiercebiotech.com/medtech/sequel-med-tech-connects-twiist-insulin-pump-abbotts-cgm-ahead-market-debut XX Dexcom's longer-lasting CGM sensor looks promising, based on study results presented at the conference. The trial showed that the new 15-day G7 system is slightly more accurate than the current G7. The accuracy of CGM can be measured using MARD (mean absolute relative difference), which shows the average amount a CGM sensor varies from your actual glucose levels (a lower number is better).  The 15-day G7 has a MARD value of 8.0%, about the same as the Abbott Freestyle Libre 3. The Dexcom G7 15 Day is awaiting FDA approval and is not yet available in the U.S.   XX Little bit of news from Modular Medical.. they plan to submit their patch pump to the FDA late summer or fall of this year. The MODD1 product, a 90-day patch pump, features new microfluidics technology to allow for the low-cost pumping of insulin. Its new intuitive design makes the product simple to use and easier to prescribe. It has a reservoir size of 300 units/3mL. Users can monitor the pump activity with their cell phone and do not require an external controller. The pump uses a provided, single-use, disposable battery. Modular Medical picked up FDA clearance for MODD1 in September. The company also raised $8 million to end 2024. Its founder, Paul DiPerna, previously founded leading insulin pump maker Tandem Diabetes Care. DiPerna invented and designed Tandem's t:slim pump. By developing its patented insulin delivery technologies, the company hopes to improve access to glycemic control. Its founder, Paul DiPerna, previously founded leading insulin pump maker Tandem Diabetes Care. DiPerna invented and designed Tandem's t:slim pump. https://www.drugdeliverybusiness.com/modular-medical-announces-12m-private-placement/ XX More from attd – type 2 news? https://www.drugdeliverybusiness.com/biggest-diabetes-tech-news-attd-2025/ XX Another study that says people with type 1 who use a GLP-1 medication get better outcomes. In this study, those who use GLP-1 with insulin are 55% less likely to have a hyperglycemia-related ED visit, 26% less likely to have an amputation-related visit, and 29% less likely to have a diabetic ketoacidosis (DKA)-related ED visit in the following year compared to those on insulin alone. Although they are not approved for T1D, some patients may receive them off-label or for weight control. Pretty big study for an off label drug: compared 7,010 adult patients with T1D who were prescribed GLP-1s and insulin to 304,422 adult patients with T1D who were on insulin alone.  It is important to note that the rates of new diabetic complications in one year for both groups were around 1%, indicating that these are uncommon outcomes regardless of medication use. https://www.epicresearch.org/articles/some-diabetic-complications-less-likely-among-type-1-diabetics-on-glp-1s   XX Early research here but exposure to antibiotics during a key developmental window in infancy may stunt the growth of insulin-producing cells in the pancreas and boost risk of diabetes later in life The study, is published this month in the journal Science, it's a study in mice. These researchers are working off the idea that when while identical twins share DNA that predisposes them to Type 1 diabetes, only one twin usually gets the disease. She explained that human babies are born with a small amount of pancreatic “beta cells,” the only cells in the body that produce insulin.   But some time in a baby's first year, a once-in-a-lifetime surge in beta cell growth occurs.   “If, for whatever reason, we don't undergo this event of expansion and proliferation, that can be a cause of diabetes,” Hill said.   They found that when they gave broad-spectrum antibiotics to mice during a specific window (the human equivalent of about 7 to 12 months of life), the mice developed fewer insulin producing cells, higher blood sugar levels, lower insulin levels and generally worse metabolic function in adulthood.   in other experiments, the scientists gave specific microbes to mice, and found that several they increased their production of beta cells and boosted insulin levels in the blood. When male mice that were genetically predisposed to Type 1 diabetes were colonized with the fungus in infancy, they developed diabetes less than 15% of the time. Males that didn't receive the fungus got diabetes 90% of the time. Even more promising, when researchers gave the fungus to adult mice whose insulin-producing cells had been killed off, those cells regenerated. Hill stresses that she is not “anti-antibiotics.” But she does imagine a day when doctors could give microbe-based drugs or supplements alongside antibiotics to replace the metabolism-supporting bugs they inadvertently kill.   .   “Historically we have interpreted germs as something we want to avoid, but we probably have way more beneficial microbes than pathogens,” she said. “By harnessing their power, we can do a lot to benefit human health.”     https://www.eurekalert.org/news-releases/1078112 XX Future watch for something called BeaGL - created by researchers at the University of California Davis and UC Davis Health who were inspired by their own personal experiences with managing T1D.   BeaGL is designed to work with CGMs and has security-focused machine learning algorithms to make predictive alerts about anticipated glucose changes, which are sent to a device. In this case, a smartwatch. The end goal is for BeaGL to be completely automated to reduce the cognitive load on the patient, particularly for teens. It's still in research phase but six student with T1D have been using it for almost a year.     https://health.ucdavis.edu/news/headlines/with-ai-a-new-metabolic-watchdog-takes-diabetes-care-from-burden-to-balance/2025/02 XX Investigators are searching for a way forward after two long-term diabetes programs were terminated following the cancellation of their National Institutes of Health (NIH) funding, the result of federal allegations that study coordinator Columbia University had inappropriately handled antisemitism on campus. The programs include the three-decades-old Diabetes Prevention Program (DPP) and its offshoot, the Diabetes Prevention Program Outcomes Study (DPPOS). “We are reeling,” said David Nathan, MD, a previous chair of both the DPP and the DPPOS and an original leader of the landmark Diabetes Control and Complications Trial. Nathan is also founder of the Massachusetts General Hospital Diabetes Center in Boston, one of the 30 DPPOS sites in 21 states. On March 7, the Trump administration cancelled $400 million in awards to Columbia University from various federal agencies. While Columbia University agreed on March 21 to changes in policies and procedures to respond to the Trump administration's charges, in the hopes that the funding would be restored, DPPOS Principal Investigator Jose Luchsinger, MD, told Medscape Medical News that as of press time, the study was still cancelled. https://www.medscape.com/viewarticle/diabetes-prevention-program-cancellation-colossal-waste-2025a100076h XX XX Type 2 diabetes may quietly alter the brain in ways that mimic early Alzheimer's. This was only an animal study – but researchers say the high comorbidity of type 2 diabetes (T2D) with psychiatric or neurodegenerative disorders points to a need for understanding what links these diseases.   https://scitechdaily.com/how-diabetes-quietly-rewires-the-brains-reward-and-memory-system/ XX Eating chili once a month when you're pregnant seems to lower the risk of developing gestational diabetes. This is a real study! While chili showed a link to lower gestational diabetes risk, dried beans and bean soup had no significant effect, even among women who ate them more frequently. Some studies suggest that diets high in beans and legumes, including the Mediterranean diet, reduce GDM risk. While studies link beans to lower diabetes risk, their specific impact on GDM remains unclear. This study analyzed data from 1,397 U.S. pregnant women who participated in the Infant Feeding Practices Study II, conducted between 2005 and 2007. Chili consumption varied significantly by race, education, household size, income, supplemental nutrition status, and region. Non-Hispanic Black mothers consumed the most (0.33 cups/week), while those with higher income and education levels consumed less. Regional differences also influenced chili intake. One possible mechanism for chili's effect is capsaicin, a bioactive compound found in chili peppers, which has been linked to metabolic benefits in other studies. However, further research is needed to confirm this potential role in GDM prevention. Dried bean and bean soup consumption had no clear association with GDM. The study highlights limitations due to self-reported dietary data and the need for more detailed dietary measures. https://www.news-medical.net/news/20250317/Could-a-little-spice-in-your-diet-prevent-gestational-diabetes.aspx XX

Former NIH director Dr. Harold Varmus speaks out about what recent budget cuts and policy changes could mean for science.One of the areas targeted by President Trump's administration for cuts has been the National Institutes of Health (NIH). Cost-cutting actions have included the layoffs of some 1,200 NIH employees, the termination of research grants, a pause in the “study sections” that evaluate and award grant funding, and a cap on indirect costs included in research grants. Some of those moves have been paused following court cases. Dr. Harold Varmus, a former director of the National Institutes of Health, joins Host Ira Flatow to talk about the actions, and the impact he fears they could have on the future of biomedical research in the United States.Transcripts for each segment will be available after the show airs on sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

This episode has three chapters. Each one answers a key question, and, bottom line, it all adds up to action steps directly and indirectly for many, including plan sponsors probably, community leaders, and also hospital boards of directors. Here's the three chapters in sum. For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. Chapter 1: Are commercial insurance premiums rising faster than the inflation rate? And if so, is the employee portion of those premiums also rising, meaning a double whammy for employees' paychecks (ie, premium costs are getting bigger and bigger in an absolute sense, and also employees' relative share of those bigger costs is also bigger)? Spoiler alert: yes and yes. Chapter 2: What is the biggest reason for these premium increases? Like, if you look at the drivers of cost that underpin those rising premiums, what costs a lot that is making these premiums cost a lot? Spoiler alert: It's hospitals and the price increases at hospitals. And just in case anyone is wondering, this isn't, “Oh, chargemasters went up” or some kind of other tangential factor. We're talking about the revenue that hospitals are taking on services delivered has gone up and gone up way higher than the inflation rate. In fact, hospital costs have gone up over double the amount that premiums have gone up. Wait, what? That's a fact that Dr. Vivian Ho said today that threw my brain for a loop: Hospital costs have gone up over double the amount that premiums have gone up. Chapter 3: Is the reason that hospital prices have rocketed up as they have because the underlying costs these hospitals face are also going up way higher than the inflation rate? Like, for example, are nurses' salaries skyrocketing and doctors are getting paid a lot more than the inflation rate? Stuff like this. Too many eggs in the cafeteria. Way more charity care. Bottom line, is an increase in underlying costs the reason for rising hospital prices? Spoiler alert: no. No to all of the above. And I get into this deeply with Dr. Vivian Ho today. But before I do, I do just want to state with three underlines not all hospitals are the same. But yeah, you have many major consolidated hospitals crying about their, you know, “razor-thin margins” who are, it turns out, incentivizing their C-suites to do things that ultimately wind up raising prices. I saw a PowerPoint flying around—you may have seen it, too—that was apparently presented by a nonprofit hospital at JP Morgan, and it showed this nonprofit hospital with a 15.1% EBITDA (earnings before interest, taxes, depreciation, and amortization) in 2024. Not razor thin in my book. It's a, the boards of directors are structuring C-suite incentives in ways that ultimately will raise prices. If you want to dig in a little deeper on hospital boards and what they may be up to, listen to the show with Suhas Gondi, MD, MBA (EP404). Vivian Ho, PhD, my guest today, is a professor and faculty member at Rice University and Baylor College of Medicine. Her most major role these days is working on health policy at Baker Institute at Rice University. Her work there is at the national, state, and local levels conducting objective research that informs policymakers on how to improve healthcare. Today on the show, Professor Vivian Ho mentions research with Salpy Kanimian and Derek Jenkins, PhD. Alright, so just one quick sidebar before we get into the show. There is a lot going on with hospitals right now. So, before we kick in, let me just make one really important point. A hospital's contribution to medical research, like doing cancer clinical trials, is not the same as how a hospital serves or overcharges their community or makes decisions that increase or reduce their ability to improve the health and well-being of patients and members who wind up in or about the hospital. Huge, consolidated hospital networks can be doing great things that have great value and also, at the exact same time, kind of harmful things clinically and financially that negatively impact lots of Americans and doing all of that simultaneously. This is inarguable. Also mentioned in this episode are Rice University's Baker Institute for Public Policy; Baker Institute Center for Health Policy; Suhas Gondi, MD, MBA; Salpy Kanimian; Derek Jenkins, PhD; Byron Hugley; Michael Strain; Dave Chase; Zack Cooper, PhD; Houston Business Coalition on Health (HBCH); Marilyn Bartlett, CPA, CGMA, CMA, CFM; Cora Opsahl; Claire Brockbank; Shawn Gremminger; Autumn Yongchu; Erik Davis; Ge Bai, PhD, CPA; Community Health Choice; Mark Cuban; and Ferrin Williams, PharmD, MBA. For further reading, check out this LinkedIn post.   You can learn more at Rice University's Center for Health Policy (LinkedIn) and Department of Economics and by following Vivian on LinkedIn.   Vivian Ho, PhD, is the James A. Baker III Institute Chair in Health Economics, a professor in the Department of Economics at Rice University, a professor in the Department of Medicine at Baylor College of Medicine, and a nonresident senior scholar in the USC Schaeffer Center for Health Policy and Economics. Ho's research examines the effects of economic incentives and regulations on the quality and costs of health care. Her research is widely published in economics, medical, and health services research journals. Ho's research has been funded by the National Institutes of Health (NIH), the Agency for Healthcare Research and Quality, the American Cancer Society, and Arnold Ventures. Ho has served on the Board of Scientific Counselors for the National Center for Health Statistics, as well as on the NIH Health Services, Outcomes, and Delivery study section. She was elected as a member of the National Academy of Medicine in 2020. Ho is also a founding board member of the American Society for Health Economists and a member of the Community Advisory Board at Blue Cross Blue Shield of Texas. Ho received her AB in economics from Harvard University, a graduate diploma in economics from The Australian National University, and a PhD in economics from Stanford University.   05:12 Are insurance premiums going up? 05:59 What is the disparity between cost of insurance and wage increases? 06:21 LinkedIn post by Byron Hugley. 06:25 Article by Michael Strain. 06:46 How much have insurance premiums gone up for employers versus employees? 09:06 Chart showing the cost to insure populations of employees and families. 10:17 What is causing hospital prices and insurance premiums to go up so exponentially? 12:53 Article by (and tribute to) Uwe Reinhardt. 13:49 EP450 with Marilyn Bartlett, CPA, CGMA, CMA, CFM. 14:01 EP452 with Cora Opsahl. 14:03 EP453 with Claire Brockbank. 14:37 EP371 with Erik Davis and Autumn Yongchu. 15:28 Are razor-thin operating margins for hospitals causing these rising hospital prices? 16:56 Collaboration with Marilyn Bartlett and the NASHP Hospital Cost Tool. 19:47 What is the explanation that hospitals give for justifying these profits? 23:16 How do these hospital cost increases actually happen? 27:06 Study by Zack Cooper, PhD. 27:35 EP404 with Suhas Gondi, MD, MBA. 27:50 Who typically makes up a hospital board, and why do these motivations incentivize hospital price increases? 30:12 EP418 with Mark Cuban and Ferrin Williams, PharmD, MBA. 33:17 Why is it vital that change start at the board level?   You can learn more at Rice University's Center for Health Policy (LinkedIn) and Department of Economics and by following Vivian on LinkedIn.   Vivian Ho discusses #healthinsurance #premiums and #hospitalpricing on our #healthcarepodcast. #healthcare #podcast #changemanagement #healthcareleadership #healthcaretransformation #healthcareinnovation   Recent past interviews: Click a guest's name for their latest RHV episode! Chris Crawford (EP465), Al Lewis, Betsy Seals, Wendell Potter (Encore! EP384), Dr Scott Conard, Stacey Richter (INBW42), Chris Crawford (EP461), Dr Rushika Fernandopulle, Bill Sarraille, Stacey Richter (INBW41)  

Janet A. Jokela, an infectious disease physician, discusses her article, "Doctors, grounded in our oath, must act now more than ever," reflecting on the physician's solemn commitment to patient care, integrity, and advocacy. With increasing challenges to public health institutions like the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and World Health Organization (WHO), physicians must decide how to uphold their oath amid political and systemic disruptions. The conversation explores the role of medical professionals in defending science, advocating for patients, and maintaining ethical standards in health care. Listeners will gain insights into actionable steps, from professional advocacy to public communication, that reinforce the vital responsibility physicians carry both inside and outside the clinical setting. Our presenting sponsor is Microsoft Dragon Copilot. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Now you can streamline and customize documentation, surface information right at the point of care, and automate tasks with just a click. Part of Microsoft Cloud for Healthcare, Dragon Copilot offers an extensible AI workspace and a single, integrated platform to help unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise—and it's built on a foundation of trust. It's time to ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended GET CME FOR THIS EPISODE → https://www.kevinmd.com/cme I'm partnering with Learner+ to offer clinicians access to an AI-powered reflective portfolio that rewards CME/CE credits from meaningful reflections. Find out more: https://www.kevinmd.com/learnerplus

The acting head of the NIH reportedly pushed back against legal guidance to resume grant funding, leaving federal workers in the lurch. Also, though fungi make up a tiny part of the human microbiome, they play an important role in both the prevention and development of many diseases.Cuts And Conflicting Directives Sow Confusion For NIH WorkersJust over a month after President Trump's inauguration, federal science in the US is in a state of disarray. Executive orders to halt grant funding at the National Institutes of Health (NIH) have faced court challenges. Last week, a federal judge extended a restraining order on a proposal to cap NIH grant funding for indirect costs, costs that experts say are critical to their work. But according to new reporting, staff within the NIH have been left without clear guidance about moving forward with those grants, with the NIH's acting director reportedly pushing back against legal guidance from the agency's lawyers to restart distribution of the funding.Host Flora Lichtman is joined by Katherine J. Wu, staff writer for The Atlantic, who reported on the turmoil at the NIH. They also talk about other science news of the week, including an update on the measles outbreak in Texas, how to see every planet in the solar system this week, and how scientists think runner Faith Kipeygon could be the first woman to break a four-minute mile.You've Heard Of The Microbiome—Welcome To The MycobiomeYou've heard of the microbiome, the community of bacteria, viruses, archaea parasites, and fungi that live in our bodies. But that last member of the group, fungi, get a lot less attention than the others. And perhaps that's unsurprising. After all, bacteria outnumber fungi 999 to 1 in our guts.But now, scientists are beginning to piece together just how important fungi truly are. Disruption in the fungal balance can play a role in the development of Crohn's disease, irritable bowel disease, celiac disease, colorectal cancer, some skin diseases, and more.Host Flora Lichtman talks with Dr. Mahmoud Ghannoum, microbiologist and professor at Case Western Reserve University's School of Medicine, who has dedicated his career to studying the fungi in our bodies, and coined the term mycobiome over a decade ago.Transcripts for each segment will be available after the show airs on sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

It's Hump Day! Sam speaks with Jackie Flynn Mogensen, reporter covering science and health at Mother Jones, to discuss her recent reporting on the Trump administration's actions towards the National Institutes of Health (NIH). Then, he speaks with Elie Mystal, justice correspondent at The Nation, to discuss his recent piece on the Trump administration's to dismantle DEIA efforts across the federal government. First, Sam runs through updates on the potential blockage of Trump's federal funds freeze, Trump's attempt to push out federal workers, Elon's interns' influence at the OPM, the gutting of the Equal Opportunity Commission, a trans care ban for anyone 19 and under, education funding, and Trump's grotesque immigration regime, before expanding on the enthusiasm from conservative media over Trump taking a sledgehammer to the government's ability to govern. Jackie Flynn Mogensen then joins, diving right into the devastating impact of Trump's first wave of federal funding freezes on the US public health regime, unpacking the pause on the NIH's $40B in funding to outside research – funding that spurs over a 2:1 return in economic activity – alongside the complete cut off of communications between health departments both internally and with the public. After expanding on the importance of broad-scale scientific research, Mogensen walks Sam through the drastic increase in insecurity and precarity among federal workers in these organizations, and why all of this dysfunction is ultimately the point of Trump's attacks on US public health infrastructure. Elie Mystal and Sam then unpack the utter nihilism of the Trump Administration's approach to the rule of law, particularly when bolstered by a Supreme Court intent on the destruction of the very same government. Next, Mystal walks through Trump's ongoing attack on DEI and DEIA policies, exploring their role as the white response to needing to “prove” the enforcement of the Civil Rights and Americans with Disabilities Acts, and what a world where the federal government refuses to act as an equal opportunity employer, nor defend equal opportunity employment, would look like. After touching on the Supreme Court's role in potentially bolstering Trump's executive takeover of the federal government – and why even a rebuke of Trump could spell trouble for future Democratic presidents – Elie and Sam wrap up with Democratic Leadership's failure to address any element of the material devastation Trump has already wrought on the country in less than two weeks. And in the Fun Half: Sam expands on the devastating impact of the “chaos is the point” ethos of the Trump Administration and the absurdity of blaming those materially affected over their vote, also touching on the utter failure of Democratic leadership to address this destruction, and looking at how a genuinely engaged opposition leader would respond to Trump in the form of JB Pritzker. Next, the MR Crew unpacks Rep. Rich Cormick's explanation on why taking away meals from kids is fine, actually, gets a window into the world of Harlan Crow from Redford in Dallas, and touches on the Trump Admin's decision to reverse (and maybe reverse the reversal?) of the recent OMB memo. They also dive deep into the devastating impact of Trump's first ten days on the agriculture industry, and watch RFK get grilled over his myriad dangerous hypocrisies, plus, your calls and IMs! Follow Jackie on Twitter here: https://x.com/jackiefmogensen Check out Jackie's work at Mother Jones here: https://www.motherjones.com/author/jackie-flynn-mogensen/ Follow Elie on Twitter here: https://x.com/ElieNYC Check out Elie's work at The Nation here: https://www.thenation.com/authors/elie-mystal/ Become a member at JoinTheMajorityReport.com: https://fans.fm/majority/join Follow us on TikTok here!: https://www.tiktok.com/@majorityreportfm Check us out on Twitch here!: https://www.twitch.tv/themajorityreport Find our Rumble stream here!: https://rumble.com/user/majorityreport Check out our alt YouTube channel here!: https://www.youtube.com/majorityreportlive Gift a Majority Report subscription here: https://fans.fm/majority/gift Subscribe to the ESVN YouTube channel here: https://www.youtube.com/esvnshow Subscribe to the AMQuickie newsletter here: https://am-quickie.ghost.io/ Join the Majority Report Discord! https://majoritydiscord.com/ Get all your MR merch at our store: https://shop.majorityreportradio.com/ Get the free Majority Report App!: https://majority.fm/app Go to https://JustCoffee.coop and use coupon code majority to get 10% off your purchase! Check out today's sponsors: Nutrafol: Start your hair growth journey with Nutrafol. For a limited time, Nutrafol is offering our listeners ten dollars off your first month's subscription and free shipping when you go to https://Nutrafol.com and enter the promo code TMR. Find out why over 4,500 healthcare professionals and stylists recommend Nutrafol for healthier hair. That's https://Nutrafol.com, promo code TMR. Smalls Cat Food: For 50% off your first order, head to https://www.smalls.com and use code MAJORITY. Follow the Majority Report crew on Twitter: @SamSeder @EmmaVigeland @MattLech @BradKAlsop Check out Matt's show, Left Reckoning, on Youtube, and subscribe on Patreon! https://www.patreon.com/leftreckoning Check out Matt Binder's YouTube channel: https://www.youtube.com/mattbinder Subscribe to Brandon's show The Discourse on Patreon! https://www.patreon.com/ExpandTheDiscourse Check out Ava Raiza's music here! https://avaraiza.bandcamp.com/ The Majority Report with Sam Seder - https://majorityreportradio.com/